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The nuclear lamina is a protein meshwork at the inner side of the inner nuclear membrane
and connects to essential cellular structures like chromatin, the nuclear pore complex and the
cytoskeleton. The nuclear lamina is comprised of A-type lamins (lamin A, C and C2), B-type
lamins (lamin B1, B2 and B3) and lamina associated proteins. Progerin is a altered form of
Lamin A, which causes severe ageing-like effects of the Hutchinson-Gilford progeria syndrome.
Progerin was also found in cells of normal aged individuals. Therefore, it is conceivable that the
expression of Progerin is linked to the process of ageing and its effects. How the cellular effects
of Progerin expression, like misfolded nuclei, decreased heterochromatin, increased apoptosis
and increased DNA damage are mediated from the cellular to the organismic level is not well
understood. It is conceivable however that stem cells play an important role in this process,
since the early loss of hair is a typical symptom of HGPS and in HGPS-mouse-models a decrease
of hair-follicle stem cell proliferation was reported. Also the loss of subcutaneous fat and reduced
wound healing, found in HGPS patients and elderly people, indicates impairment of stem cell
function. In Drosophila expression of the lamina proteins lamin Dm0 and Kugelkern induces
effects similar to those observed in HGPS patients and HGPS-animal-models. In the course of
this work, lamin Dm0 and Kugelkern were found to drastically reduce stem cell proliferation
in the Drosophila midgut. Since the midgut is a relatively simple organ, with only 5 cell types
and low degree of infoldings, it offers many benefits as a system to study stem cell behavior;
and in this context, the effect of lamin Dm0 and Kugelkern on intestinal stem cells.
In this work the mechanism in which lamin Dm0 and Kugelkern act on intestinal stem cells
was investigated. It is shown, that lamin Dm0 Kugelkern overexpression does not permanently
damage intestinal stem cells or impair their function irreversibly. That the effects of lamin
Dm0 and Kugelkern overexpression are likely not due to impaired nuclear transport. And that
the inhibiting effect of lamin Dm0 on ISC proliferation is pinpointed to the impairment of the





The nucleus is a distinctive feature of eukaryotic cells and separates the chromatin from the cy-
toplasm via the nuclear envelope. The nuclear envelope of metazoans is comprised of three main
elements: the nuclear pores, the nuclear membrane and the nuclear lamina [33] (Figure 1). The
nuclear membrane consists of two lipid bilayers: the outer nuclear membrane (ONM) and the
inner nuclear membrane (INM). The space between ONM and INM is called perinuclear space
(PNS). The ONM and the PNS are continuous with the endoplasmatic reticulum (ER), while
the INM associates with the nuclear lamina. The nuclear membrane is perforated by nuclear
pore complexes (NPCs), which serve as gateways to regulate the transfer of macromolecules
between nucleus and cytoplasm [35].
The nuclear lamina is a metazoan-specific protein meshwork located at the inner side of
the INM. The lamina binds to the periphery of NPCs, to chromatin and is connected with
the cytoskeleton and INM via a diverse set of lamina binding proteins and lamina associated
proteins [1, 29, 31, 60, 72, 93]. The main structural component of the lamina are lamins,
which are categorized as class V intermediate filaments [70] and are in fact the only nuclear
intermediate filaments [84]. Based on sequence homology, lamins are categorized into A and
B type lamins. Mammals have three A-type lamins (lamin A, C and C2, encoded by the
LMNA gene) and three B-type lamins (lamin B1, encoded by LMNB1 and lamin B2 and B3,
encoded by LMNB2 ). As intermediate filaments, the lamin structure involves a head domain,
an alpha-helical rod domain and a C-terminal tail domain. Additionally, they contain an
immunoglobulin fold-like structure with β-sheets, a nuclear localization signal (NLS) in the tail
domain and, except for Lamin C, they also contain a C-terminal CaaX motif (C = cysteine, a
= aliphatic residues, X = any residue) [47, 84]. During the maturation of lamin A and B-type
lamins, the CaaX motif undergoes a series of post-translational processing steps resulting in the
addition of a farnesyl group at the last cysteine. The CaaX motif is considered to play a role
in the targeting of lamins to the INM and in protein-protein interactions [76]. Lamin A and B
are likely to interact with each other in vitro [32]. Also scanning electron microscopy images of
nuclear envelopes of Xenopus laevis oocytes have shown an ordered meshwork of filaments [2].
However, little is known about the way in which lamins interact; whether they form a single
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Figure 1: Nuclear Lamina
Schematic of the nuclear lamina, lamina proteins and associated cellular organelles. ER: Endoplasmatic reticu-
lum, NPC: Nuclear pore complex, ONM:Outer nuclear membrane, PNS: Perinuclear space, INM: Inner nuclear
membrane, Lamin binding proteins: LBR, LAP1, LAP2, Emerin, MAN1, SUN1/2, Lamina associated proteins:
BAF, HP1, Nesprin. Adopted from [83].
interconnected network or layers of different types of lamins [90].
1.2 Laminopathies and HGPS
Since the discovery, in 1999, that autosomal dominant Emery-Dreifuss muscular dystrophy
was caused by a mutation in the LMNA gene [10], many other diseases have been linked to
heterozygous mutations in the same allele (Figure 2). These diseases are termed laminopathies
and can be categorized into two main branches: “tissue-specific laminopathies” affecting muscle,
fat or nerve tissue or “systemic laminopathies” like progeroid diseases affecting a wide range of
tissues. Until now 464 different mutations have been found in the LMNA gene in a total of 2251
subjects. In contrast to this very few diseases are linked to mutations in LMNB1/B2. LMNA
mutations leading to “tissue-specific laminopathies” are the most prominent (UMD-LMNA
mutations database). However, the smaller set of “systemic laminopathies” contains a collection
of premature ageing diseases which may help to understand the complex processes involved in
ageing. One of the most prominent examples of this group is the Hutchinson-Gilford progeria
syndrome (HGPS).
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Figure 2: Laminopathies
Schematic of LMNA mutations that induce different types of laminopathies overlayed on the lamin A/C protein.
Dominant disorders as a result of heterozygous LMNA mutations are depicted on the top of the protein scheme,
whereas homozygous mutations, causing recessive laminopathies, are presented below. Numbers of people with
the respective LMNA mutation and the corresponding phenotype are noted in parentheses close to each disease
acronym (2006). cdc2: site of Cdc2 kinase, HDC: highly conserved domain, NLS: nuclear localization signal.
Adopted from [15].
Hutchinson-Gilford progeria syndrome
HGPS is a rare genetic disease that starts affecting patients in early infancy, leading to several
ageing associated phenotypes like growth retardation, premature atherosclerosis, loss of subcu-
taneous fat, altered pigmentation, decreased wound healing, osteolysis and loss of hair. While
many phenotypic aspects of HGPS are also found in elderly people, some symptoms associated
with ”normal ageing”, like neurodegeneration, type 2 diabetes, hyperlipidemia or cancer dis-
position, are absent in HGPS patients [23, 34, 42, 58, 77, 86]. HGPS can be subdivided into
clasical HGPS and atypical HGPS. Atypical HGPS shares several of the phenotypes of classical
HGPS but not all an with varying degree [42]. Atypical HGPS can be caused by a homozygous
1579C>T mutation in exon 9 of LMNA [42, 49].
The classical HGPS phenotype is generated in two main ways:
1. A silent G608G (GGC -> GGT) mutation within exon 11 of the LMNA gene (90% of
patients) results in a constitutive activation of a cryptic splice site. This leads to a 50-amino
acid deletion in Prelamin A (amino acids 607–656), thereby removing the recognition site for
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the metalloproteinase ZMPSTE2 that normally cleaves off the last 15 C-terminal amino acids
together with the farnesyl group [23, 27].
2. A mutation in the ZMPSTE2 gene locus itself resulting in a dysfunctional ZMPSTE2
protein [22].
In both cases the C-terminal part of Prelamin A with the farnesyl group is not cleaved off
resulting in a truncated and permanently farnesylated form of prelamin A, termed Progerin.
On a cellular level Progerin expression causes a multitude of harmful effects: nuclear abnor-
malities like blebs and invaginations, resulting in decreased nuclear stability [92], decreased
heterochromatin [21], defective DNA repair, decreased genome stability and a chronic DNA-
damage response [53, 54], reduced telomere length [24] and increased apoptosis [14].
Some evidence suggests that stem cells might play a role in HGPS. It was shown that stem
cells from HGPS patients express Progerin [87] and that mesenchymal stem cells (MSC) have
upregulated levels of Notch target genes [78]. This might indicate a loss of stem cell identity
since Notch plays a crucial role in the Delta/Notch pathway, which is often necessary for stem
cell/daughter cell fate determination. Another work in mice revealed that HGPS-model mice
show decreased proliferation in hair follicle stem cells [28]. This result could indicate a similar
mechanism in human HGPS patients since the early loss of hair is one of the hallmarks of
HGPS. It might also indicate a connection to the loss of hair during normal ageing because it
was found that expression of Progerin also occurs in normal individuals due to the sporadic
use of a cryptic splice site (C1824T) that regulates the splicing outcome of the LMNA gene
[68, 78]. This possibly establishes a direct link between the ageing-like phenotypes of HGPS
and normal ageing.
HGPS model in Drosophila
In contrast to vertebrates, which have lamin A, C, B1 and B2, Drosophila only has one ho-
mologue of lamin C and one homologue of B-type lamins, termed Lamin Dm0 (Drosophila
melanogaster 0). It does not have a homologue of lamin A [37]. Interestingly, Drosophila
encodes for another farnesylated lamina protein, Kugelkern (Kuk), termed after the embry-
onic phenotype of the mutant in which nuclei at the cellularization stage are round instead of
elongated [13]. Kuk, similar to lamins, contains a putative coiled coil motif in its N terminus,
a nuclear localization signal (NLS), and a CaaX motif in the C terminus (based on sequence
prediction, Figure 3) [13]. In addition to the predicted structural similarities, Kuk also is likely
to share functional similarities with Dm0, since overexpression of Kuk induces similar pheno-
types as overexpression of Dm0. In this context it was also found that overexpression of Kuk
and Dm0 induces ageing-like phenotypes and phenotypes typical for HGPS. Overexpression of
both proteins in muscle cells induced nuclear abnormalities, reduced fitness, shortened lifes-
pan, decreased heterochromatin and increased DNA damage [12]. These essential similarities
justify the conclusion that overexpression of both Dm0 and Kuk can serve as an HGPS model
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Figure 3: Lamins and Kugelkern
Scheme of Drosophila lamins (Lamin Dm0, Lamin C) and Kugelkern and human lamins (Prelamin A, Lamin
A, Lamin B, Lamin C, Progerin). N-terminus on the left, C-terminus on the right. The structural information
of displayed lamins is based on x-ray crystallography whereas the structure of Kugelkern is based on sequence
prediction. The presence of a fanesyl-rest in Kugelkern was shown by western band shift and a Kuk mutant
protein lacking the farnesylation site. NLS: Nuclear localization sequence. CAAX: Amino acid motif, necessary
for farnesylation, with C = Cysteine, A = aliphatic amino acid, X = variable amino acid. C-OCH3: methylated
C-terminus. Similar colored protein domains indicate structural (not sequential) similarity.
in flies. Interestingly ectopic expression of human lamin A and Progerin in developing and
adult stages of Drosophila also did induce some of the effects typical for HGPS, such as nuclear
deformations, reduced lifespan [70].
Dm0 function in adult flies
Dm0 plays an important role in Drosophila development. Several types of Dm0 null mutants
have been generated. In the majority of cases only a small percentile of flies reaches the imago
stage [62, 67]. Those ”escapees” can not fly and walk like aged wildtype flies. This indicates
that Dm0 plays an important role in neuromuscular function [62]. An additional function was
found in Drosophila testes and ovaries, by using FLP/FRT-mediated mitotic recombination the
authors generated Lam D395 mutant cyst stem cell clones and mutant follicle cells [18]. They
found that Dm0 is essential in these cells to activate EGFR signaling, which is required for cyst
stem cell proliferation and follicle cell function to define the AP polarity of the egg chamber
[18, 63]. Another function was published in the following year by the same group. They
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found that age related decline in Dm0 in fat bodies causes gut hyperplasia due to deregulated
intestinal stem cell proliferation [19]. The fat body plays an important role as an immune
organ, upon microbial infection it created a strong inflammatory response that helps to fend of
invading microbes. However upon age related decline or knockout of Dm0 the fat body secretes
peptidoglycan recognition proteins that suppress local intestinal immune deficiency signaling.
Local intestinal immune deficiency signaling is known to negatively regulate excessive intestinal
stem cell proliferation to maintain homeostasis [3, 17]. Therefore suppression of intestinal
immune deficiency signaling by fat body secreted peptidoglycan recognition proteins causes
loss of homeostasis.
Since Dm0 has an essential function in cyst stem cells of the testes, it is possible that Dm0 has
similar functions in intestinal stem cells. The midgut, testes and ovaries are the only stem cell
harboring organs in Drosophila. However, no such function has yet been reported, therefore it
is plausible to test this hypothesis in this work.
1.3 Homeostasis and regeneration in the Drosophila
midgut
Stem cells play a key role in regeneration and maintenance of tissues. They are undifferentiated
cells that, depending on their hierarchy, form all other cells in a tissue, organ or organism [85].
Upon damage of a tissue, stem cells, regulated by signaling cues from the surrounding tissue,
replace the damaged cells to maintain an equilibrium of newly formed and disposed cells. This
process is termed homeostasis. Signaling cues are often also needed to maintain stem cells in
their present number and location; in many tissues, specific cells in the vicinity of a stem cell
remain in constant signaling crosstalk with it to achieve just that. Together they form a stem
cell niche [82]. The decline of stem cell functionality is one of the hallmarks of the ageing
process though it is often unclear whether this decline is caused by extrinsic (altered niche
signaling) or intrinsic factors (decreased telomere length, increased number of mutations) [61].
Reduced regenerative capacity of tissues and organs and eventually functional failure is often
cause of death in the elderly [44, 64, 75, 80, 79]. Therefore to study the ageing process and
eventually ameliorate or reverse its harmful effects, proper understanding of stem cell function
and regulation is necessary. However, since humans are difficult first hand research objects the
use of model organisms to study stem cell behavior is a well established practice. In this work
the Drosophila midgut is used as a model system to study stem cell regulation. This combines
the powerful genetic tools of the Drosophila model-organism with a relatively simple system
for stem cell regulation.
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Figure 4: The Drosophila midgut
Dissected male gut with the following compartments: 1 proventriculus, 2 midgut, 3 hindgut, 4 rectum, 5 last
abdominal segment and sexual organs, 6 malpighian tubules. (altered picture, diploma thesis, Roman Petrovsky)
The Drosophila midgut, a model system for stem cell behavior in vivo
The Drosophila melanogaster imago (adult stage) is a post-mitotic organism. Only two organ
types are known to harbor stem cells in Drosophila imagos: the reproductive system and the
midgut. This is plausible since in these systems the need for stem cell proliferation is highest;
ovaries and testes constantly produce new germ cells and the midgut, due to its exposure
to harmful agents in the food, needs to regenerate lost or damaged cells. The Drosophila
midgut (Figure 4) has several advantages as a model system for stem cell behavior : It is a
pseudostratified monolayered epithelium of cells without deep infoldings, simplifying imaging
approaches (Figure 5 A). It is in direct contact to food, thereby giving direct access to the
application of agents, altering stem cell behavior (i.e. bleomycin or Pseudimonas entomophila)
It is a simple system to study stem cell behavior in vivo. The Drosophila midgut is comprised
of only five cell types (Figure 5 B, 6): 1. Intestinal stem cells (ISCs) are the only cells that
undergo division and thereby regenerate damaged cells [59, 65], 2. Absorptive enterocytes
(ECs) are polyploid and form the majority of the gut mass, 3. Secretory enteroendocrine cells
(EEs) secrete digestive enzymes [59, 65], 4. Enteroblasts (EBs) are post-mitotic progenitor cells
for ECs and EEs, 5. Viceral muscle cells regulate maintenance of the stem cell pool and give
stability to the gut and promote movement of the food through the intestine [51, 66].
Signaling and homeostasis in the Drosophila midgut
The ordered replacement of damaged cells is one of the challenges of tissues to maintain home-
ostasis. Therefore, a well balanced signaling system is needed to regulate the proliferation of
stem cells and differentiation of progenitor cells. In the Drosophila midgut, a set of six signaling
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Figure 5: Cell types of the Drosophila midgut
(A) Onview of the Drosophila midgut. Immunostaining with merged channels of GFP (marking ISCs/EBs),
and Lamin-Dm0. ISC/EB: intestinal stem cell/enteroblast, EE: secretory enteroendocrine cell, EC: enterocyte.
(B) Sideview of the Drosophila midgut. Immunostaining with merged channels of GFP (marking ISCs/EBs),
DAPI, Lamin-Dm0 and actin (stained by phalloidin). ISC/EB: Intestinal stem cell (ISC, precurser for EBs)/en-
teroblast (EB, precursor cell for EEs and ECs). Both marked by GFP. EE: Enteroendocrine cell (secretory cell).
EC: Enterocyte (absorbtive cell), VM: Viceral muscle cell.
pathways is reported to regulate the proliferation of ISCs and differentiation of EBs into EEs
and ECs: Upon damage the Jun N-terminal kinase (JNK) signaling pathway is activated in
ECs, which leads to the secretion of cytokines (Unpaired 1, 2, 3) and mitogens (EGFs) that
in turn lead to secretion of Vn and EGFs from EBs and the visceral muscle. This leads to the
activation of EGFR/Ras/MAPK, JAK/STAT and Wg/Wnt signaling in the ISCs [8, 9, 16, 43].
The Hippo pathway serves as an additional stress sensor; inactivation in ISCs induces their
proliferation while inactivation in ECs leads to secretion of cytokines, which in turn induce ISC
proliferation [81]. However, Hippo pathway induced proliferation was found to be dependent on
a basic level of JAK/STAT pathway activity [45]. All these pathways can substitute each other
but silencing of all leads to a constant decline of the stem cell population. After a regenerative
proliferation event the injury-induced BMP/Dpp pathway can downregulate ISC proliferation
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to reach maintenance levels [40].
For long term maintenance of ISCs the visceral muscle cells secrete the signaling ligands Wing-
less (Wg), Unpaired (UPD) and Vein (Vn), which activate the canonical Wnt, JAK/STAT and
EGFR signaling pathways respectively in ISCs in cooperation with signals from the epithelium
[50, 51, 52, 89]. Additionally insulin signaling from the muscle cells induces ISC proliferation
and consequently increase of the gut size, forming a mechanism to react to increased food up-
take [20].
ISC and EB identity is regulated by the Delta/Notch signaling pathway. Delta and Notch
are plasma membrane-localized ligands that are expressed differently in ISCs and EBs. ISCs
express higher levels of Delta, which activates Notch, that is expressed in higher levels by EBs
(Figure 6) [59, 65, 66]. A major target of Notch signaling in EBs are ’enhancer of split com-
plex’ target genes. ISCs are kept in an undifferentiated state by repression of the split complex
through a hairless-suppressor of hairless complex [5].
Figure 6: Mechanism of Drosophila midgut regeneration
Cell types and signaling pathways involved in homeostatic regulation of the Drosophila midgut. ISC maintenance
is controlled by Wnt and EGFR signaling from the visceral muscle cells (VMs). Upon damage ECs secrete
cytokines and mitogens which induce Wnt, EGFR, Hippo and JAK/STAT-signaling in ISCs, promoting their
proliferation. Cytokines from ECs also induce differentiation of EBs into ECs or EEs. Additionally mitogens
from ECs induce the secretion of mitogens from VMs and EBs , which induce EGFR and Wnt signaling in ISCs.
Insulin signaling from the VMs induces ISC proliferation in reaction to food intake.
24 CHAPTER 1. INTRODUCTION
1.4 Aim of the work
Overexpression of Lamin Dm0 and Kugelkern in Drosophila leads to several cellular and or-
ganismic effects that are related to symptoms of HGPS patients or phenotypes of other animal
models. One of these effects is the loss of homeostasis due to impaired stem cell function.
Since decline of stem cell function also plays a key role in normal ageing the question how this
effect is mediated is of high significance. In this work, the effects of Lamin Dm0 and Kugelkern
were analyzed in Drosophila intestinal stem cells with the aim to find underlying molecular
mechanisms that are causing the inhibition of stem cell function and loss of homeostasis.
2 Materials and Methods
2.1 Materials
2.1.1 Buffers and Solutions
Table 1: List of Buffers and Solutions
Agent Ingredients
Laemmli buffer 2x 0.09 M Tris-HCl [pH 6.8], 6% SDS, 0.6% bromophenol blue,
20% Glycerol, 6% β-mercaptoethanol
10x SDS-PAGE buffer (1L) 150 g Glycine, 10 g SDS, 32.8 g Tris base filled up with H2O
1x transfer buffer (1L) 14.4g Glycine , 2.03g Tris, 200ml Methanol filled up with
H2O
50x TAE buffer: 2M Tris/HCL [pH 8,5], 0.05M EDTA, 1M acetic acid filled up
with H2O
PBS (1L) 8g NaCl 0.2g KCl, 1.15g Na2HPO4, 0.2g KH2PO4, 0.1g
MgCl2*6H2O, 0.1g CaCl2 filled up with H2O
PBS-T 0,1% PBS, 0.1 % Tween-20
Fixation mix 0.2% Tween-20, 0.5% Nonidet P40, 8% Formaldehyde, in PBS
EM fixation mix 2.5% Glutaraldehyde, 50 mM Natrium-Cacodylate pH 7.2, 50
mM KCl, 2.5 mM MgCl2 in H2O
Permeabilization mix 0.5% Saponin, 0.5% Triton-X100, in PBS
Blocking solution 5% BSA in PBS-T
Mounting medium 47.5% glycerol, 47.5% PBS, 5% DABCO
Elastase solution 4 mg/ml Elastase in dissociation buffer
2.1.2 Chemicals and substances
All standard chemicals were purchased from AppliChem GmbH (Darmstadt), Invitrogen (Carls-
bad, USA), Merck (Darmstadt), Roth (Karlsruhe), Sigma-Aldrich (St. Louis, USA) and Gibco
BRL(Eggenstein) unless mentioned below.
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– milk powder: Magermilchpulver (SUCOFIN)
– Dissociation buffer (Sigma Aldrich)
– Rifampicin (Sigma Aldrich)
– ABT100 (MedKoo)
– Aquapolymount (Polysciences, Inc.)
– 10S and 3S VoltaLef Halocarbon oil (Lehmann & Voss & Co.)
2.1.3 Enzymes
All restriction enzymes were obtained either from Thermo Scientific (St. Leon-Rot) or New
England Biolabs (Ipswich, USA) unless mentioned below.
– Taq Polymerase (expressed and purified in the lab)
– Pfu DNA Polymerase (expressed and purified in the lab)
– T7 RNA Polymerase (expressed and purified in the lab)
– DnaseI (Roche)
– Elastase (Sigma Aldrich)
2.1.4 Bacteria
– E.coli DH5-α for molecular cloning: F-, ø80dlacZ∆M15, ∆(lacZYA-argF)U169, deoR,
recA1, endA1, hsdR17(rK –, mK+), phoA, supE44, λ–,thi-1, gyrA96, relA1
– E.coli BL21DE for protein expression: F-, dcm, ompT, hsdS(rB -mB -), gal l(DE3).
– Pseudomonas entomophila
2.1.5 Cell lines
– S2 (Drosophila genomics Research Center)
– Kc167 (Drosophila genomics Research Center)
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2.1.6 Oligonucleotides
Table 2: Oligonucleotides used in this study
Name Sequence Direction Ta °C Description
RP1 gagagatctatggagaccc
cgtcccag
sense 55 amplification of lamDelta50,
introducing a BglII site
RP2 tgatcagttatctagatccgg anti-sense 55 amplification of lamDelta50
from pYFP-lamDelta50,
including a XbaI site
RP3 gccctacctcgcagcgc sense 57 Sequencing primer for lamin
Delta50 (Progerin)
RP4 cagccttcagggtgaacttt antisense 52 Sequencing primer for lamin
Delta50 (Progerin)




sense 52 In-Fusion primer for cloning of
”Lipin b” (lipin-A-mRNA bp
2063-3743 ) into QE80ZZtev
RP13 gatgagatctggatccgga
attaatccacttgggaggc
antisense 53 In-Fusion primer for cloning of
”Lipin b” (lipin-A-mRNA bp
2063-3743 ) into QE80ZZtev
RP16 tttcattcatgccctccttga
gg





sense 55.2 seq primer for Lipin b
QE80ZZtev sense from bp1039
UASt 1 gttttatttttaataatttgcga
gtacgca
sense 56.1 For sequencing transgenes in the
MCS of the UASt vector
UASt 2 cacagaagtaaggttcctt
cacaaag
anti-sense 56.1 For sequencing transgenes in the
MCS of the UASt vector
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2.1.7 Plasmids
Table 3: Plasmids constructed in this study
Name Description
QE80ZZtev Lipin B In-Fusion cloning of Lipin B (bp 1587-3267, transcript variant A )
into the pQE80ZZtev vector for protein expression: In-Fusion
primers (RP13/RP13) were used to obtain the Lipin B PCR
product from the Ovo Ib library (created by Jörg Grosshans).
The PCR product was recombined into a unique BamHI site of
the pQE80ZZtev vector.
pUASt-Kuk Kuk sequence from pMT-Kuk vector (NotI /EcoRI) inserted into
pUASt vector (NotI /EcoRI)
UASp-Lamin∆15 PCR construct of Lamin∆15 (RP1/RP2) from pEYFP vector
inserted into pUASt vektor (BglII/XbaI)
UASp-mCherry-Kuk PCR construct of mCherry (RP8/RP9) from pMT-vector: SpeI
site is added at the beginning of the mCherry sequence, a c/g pair
is removed at the end of the sequence to prevent frameshift. GFP
sequence is removed from UASp-GFP-Kuk vector (SpeI) and
replaced by mCherry (SpeI)
Table 4: Plasmids provided by others
Name Source
QE80ZZtev provided by D. Görlich
pCS2-eGFP Constructed by Maria Polychronidou
pCS2-HA-Kuk Constructed by Y. Kussler-Schneider
1xGFP provided by M. Fornerod
2xGFP provided by M. Fornerod
5xGFP provided by M. Fornerod
10xGFP provided by M. Fornerod
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2.1.8 Antibodies
Table 5: Antibodies used in this work
Antibody Source Dilution
Primary antibodies
rabbit-α-Caspase 3 Abcam 1:500
rabbit-α-dMyc(d1-717) Santa Cruz 1:100
rabbit-α-GFP Torrey-Pines-Biolabs 1:3000
mouse-α-HP1 (Drosophila HP1) Developmental Studies Hybridoma Bank 1:1000
mouse-α-Lamin Dm0 provided by H. Saumweber 1:1000
mouse-α-Lamin C Developmental Studies Hybridoma Bank 1:1000
mouse-α-Prospero Developmental Studies Hybridoma Bank 1:100
rabbit-α-Kuk Brandt et al., 2006 1:1000
guinea-pig-α-Lamin Dm0 C-terminus provided by G. Krohne 1:250
rabbit-α-Stat92E provided by Steven X. Hou 1:1000
mouse-α-pStat92E provided by Xinhua Lin 1:2000
rabbit-α-PH3 Millipore-Upstate 1:4000
mouse-α-PH3 Millipore-Upstate 1:1000
rabbit-α-Tribbles Jörg Großhans 1:500
rabbit-α-String Glover 1:500
rabbit-α-Frühstart Jörg Großhans 1:500
guinea-pig-α-Lipin this work 1.1000
rat-α-Lipin this work 1.1000
Secondary antibodies
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2.1.9 Other reagents used in immunostainings
– DAPI (4’,6’-Diamino-2-phenylindole) from (Sigma-Aldrich): used for DNA staining, in a
final concentration of 0,05 µg/ml
– Alexa-coupled Phalloidin (Molecular Probes): used for actin staining, in a final concen-
tration of 6 nM
2.1.10 Drosophila stocks
EsgTS: Esg−Gal4, tub−GAL80TS,UAS−nlsGFPCyO
Source: Bruce Edgar lab
Esg; TS: Esg−Gal4CyO ;
tub−GAL80TS,UAS−nlsGFP
tub−GAL80TS,UAS−nlsGFP
Source: Bruce Edgar lab
Esg; TS (-GFP): Esg−Gal4CyO ;
tub−GAL80TS
TM6b




Source: Bruce Edgar lab
EsgTS; F/O: Esg−Gal4, tub−Gal80TS, UAS−nlsGFPCyO ;
act >CD2>Gal4, UAS−flippase
act >CD2>Gal4, UAS−flippase
Source: Bruce Edgar lab
UAS-UPD (UPD1): UAS−UPD26.2CyO















Source: Bloomington Drosophila Stock Center
FRT40A Lam D395/CyO: FRT40A::LamD395CyO
Source: Yixian Zheng
UAS-FUCCI: UASp−GFP−E2F1, UAS−mRFP1−NLS−CycBCyO, wg−lacZ







10g Bactotryptone, 5g Yeast extract, 10g NaCl in 1000ml ddH20
Drosophila food
20 l of H2O were cooked for 2 h with 160 g thread agar. After 2 h, 500 g fresh baker yeast, 200
g soja bean meal and 440 g molasses were added and cooked another 2 h. After 2 h cooking
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1,6 kg malt extract, 1,6 kg corn meal and 120 ml of propionic acid were added, mixed and the
food was filled in vials.
Apple juice plates
100g sugar was dissolved into 1 l of organic apple juice and kept in a 60 °C water-bath. 40ml
Nipagin solution (15% Nipagin in ethanol) was added to the apple juice. 70g agar was dissolved
into 3 l water and to this, the apple juice mixture was added, mixed and allowed to cool down
to 60 °C. The apple juice agar was poured into Petri dishes and stored at 4 °C.
ABT100, RU486 food plates
Normal Drosophila food was heated in the microwave until it reached a liquid state. The food
was cooled down to 60 °C and the respective amount of ABT100/RU486 was added to reach




– Antibody staining tubes
– Pipettes: 0.2-2 µl, 2-20 µl, 50-200 µl, 200-1000 µl Pipetman (Gilson)
– Microliter syringe: 50 µl (HAMILTON)
– micro-scissors (Tiemann)
– Eppendorf tubes: 1.5 ml, 2 ml, 5 ml (Eppendorf)
– Falcon tubes: 15 ml, 50 ml (BD Falcon)
– PCR tubes (Brand, Wertheim)
– Fly vials (Greiner)
– Glass pipettes: 5 ml, 10 ml, 20 ml, 25 ml (Silber Brandt)
– Plastic sterile pipettes 1 ml, 5 ml, 10 ml, 25 ml (Sarstedt)
– Cover slips (Menzel)
– Glass slides (Menzel)
– Parafilm ”M” (Bewis)
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– Western transfer cell: Trans-Blot SD semi-dry transfer cell (Bio-Rad)
– Pipetman: Pipetboy acu (Integra Biosciences)
– Develloper: Typ TR (Optimax)
– Developping casett
– Heater: DRI-BLOCK DB-2D (Techne)
– Centrifuges: 5415 D (Eppendorf), SS-34 (Sorvall), #3057 (Heraeus)
– Scanner: Perfection 4990 Photo (Epson)
– SDS gel electrophoresis power supply: Electrophoresis constant power supply ECPS
3000/150 (Pharmacia Fine Chemicals)
– Nitrocellulose transfer membrane: Protran (Whatman)
– medical x-ray film: Super RX, Fudji Medical X-Ray Film 100NIF 13x18 (Fujifilm)
– Scale: BP 2100 S (Satorius)
– Eppendorf Thermomixer comfort
– Fluorescence microscope: Axioplan, ZEISS Axioplan 2 (Zeiss)
– Confocal microscope: LSM 510 META (Zeiss)
– Microinjection microscope (Zeiss)
2.1.13 Kits
– MiniElute Gel extraction Kit (Qiagen)
– Plasmid Midi Kit Nucleobond AX (Macherey-Nagel)
– In-fusion HD cloning kit (Clontech)
– Arcturus PicoPure RNA Isolation Kit (Applied Biosystems, Life technologies)
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2.1.14 Software
– Lyx (LYX Team)
– Microsoft excel (Microsoft)
– Microsoft word (Microsoft)
– Adobe Photoshop CS6 (Adobe )
– Adobe Illustrator CS6 (Adobe)
– Adobe Reader (Adobe)
– FIJI (NIH)
– Zen 2012 (Carl Zeiss)
– Lasergene (GATC biotech)
– Zotero (Roy Rosenzweig Center for History and New Media)
2.2 Methods
2.2.1 Molecular cloning
All methods used for molecular cloning were carried out according to Sambrook and Russel,
2001 [39], unless otherwise stated.
2.2.2 PCR
Dependent on the purpose of the PCR either Taq or Pfu DNA polymerase was used. The
following agents were used: 50-1000 ng template DNA template (high concentrations needed
for DNA-library), 0.5 µM forward and reverse primers, 50 µM dNTP (each), 10X PCR buffer,
1-2 units (per 50 µl of reaction) Taq or Pfu polymerase. The PCR reaction was run in a
thermocycler with the following protocol:
Step 1 (Initial denaturation): 94 °C - 2 min
Step 2 (Denaturation): 94 °C - 30 sec
Step 3 (Annealing): 50-62 °C - 30 sec (depending on the annealing temperatures of the primers)
Step 4 (Elongation): 72 °C - Pfu: 2 min/1000bp Taq: 1 min/1000bp
Step 5 (Repetition of cycles) Steps 2 to 4 - 20-30 cycles
Step 6 (Final elongation) 72 °C - 10 min
Step 7 (Hold) 4 °C - ∞
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2.2.3 DNA sequencing
Sequencing was either performed by the SeqLab company or by a Sequencing service provided
by the Department of Developmental biochemistry.
2.2.4 Generation of transgenic flies
1. 3 µg of plasmid, containing the transgene with a 5’P and 3’P P-Element element (CaSpeR),
and 1µg of Delta2-3turbo (transposase) DNA were precipitated and dissolved in H2O to
a concentration of 0,1-0,5 µg/µl.
2. Embryos were dechorionated, dried in a desiccation chamber for 8-10 min and covered
with halocarbon oil.
3. The prepared DNA mix was injected into the pole plasma at the posterior tip of the
embryo, pior to pole cell formation.
4. The hatching larva (G0 generation) were transfered to a new food vial and the adult flies
crossed with the yw line.
5. The offspring (G1) was screened for yellow to red eyes and one male selected for each
grade of eye color. The male is crossed with the w; Sp/CyO; Dr/TM3, Sb double balancer
line.
6. Hatching males (G2) w; + /CyO; + /TM3, Sb were recrossed with the w; Sp /CyO; Dr
/TM3, Sb double balancer line to test for the chromosome of integration.
2.2.5 Western blotting
Dissected guts of the respective genotype were transferred into a 2 ml eppendorf tube, covered
with Laemmli buffer and ground using a grinding stick. The mix was transferred to an 1.5 ml
eppendorf tube (2 ml eppendorf vials wouldn not fit in the heating block) placed into a heater
and heated at 98 °C for 4 min. Afterwards the mix was centrifuged at 10000 g for 1 min.
The following steps: SDS-page, transfer and antibody incubation were performed according to
standard protocol [39]. Whatman paper and Whatman nitrocellulose transfer membrane were
used for transfer. Secondary antibodys were Horseradish Peroxidase-Conjugated.
Development
Incubated with a mix of solution A and B of the GE Healthcare development kit for one minute.
Put into a plastic foil and taped into a developing cassette. In the darkroom a medical x-ray
film was put into the developing cassette and exposed to the membrane for 30 seconds. Then
the medical x-ray film was put into the developer. Depending on the strength of the reaction
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and thereby the intensity of the bands on the film a second film was exposed to the membrane
either in a shorter or longer time period.
2.2.6 Induction of clones
Flipout clones were induced by keeping flies at 29 °C, 3-6 days after eclosion.
MARCM clones were induced on three consecutive days for 1 h at 37 °C, 3-6 days after
eclosion.
2.2.7 RNAseq
Four phenotypes were compared in this experiment: 1. EsgTS/CyO; Dr/TM3 (control) 2. Es-
gTS; Dm0/(Dr/TM3) (Dm0 overexpression) 3. EsgTS/UPD; +/(Dr/TM3) (UPD expression,
induction of ISC proliferation) 4. EsgTS/UPD; Dm0/(Dr/TM3) (UPD expression together
with Dm0 overexpression). From each phenotype 100-150 guts were dissected and the intesti-
nal cells dissociated by elastase treatment and agitation. The dissociated cells were transported
to the FACS facility and GFP positive cells sorted directly into RNA extraction buffer. The
mix was transported back to the lab, the RNA extracted and frozen. Each genotype was pro-
cessed 3 times in this manor (3x 100-150 guts) on different days. In the end three samples of
extracted RNA per phenotype (12 samples) were given to the „Microarray Core Facility" for
analysis.
Dissociation of Drosophila guts
100 to 150 guts, for each genotype, were dissected and transferred to a 1.5 ml Eppendorf tube
containing 400 µl of PBS. 100 µl of Elastase solution was added to reach a final concentration
of 0.8 mg/ml. The guts were incubated for 1 hour at 27 °C and agitated every 15 minutes, by
pipetting up and down about 40 times. Afterwards the mixture was centrifuged for 10 min at
600 g at 4 °C and the pellet resuspended in 500 µl PBS.
FACS
FACS was performed in the Scientific Flow Cytometry Facility of the University Medical Center
Göttingen (UMG), affiliated with the Department of Hematology and Oncology. The dissoci-
ated gut cells were applied to a 50 µm cell-sieve, removing enterocytes and cellular debris from
the solution. The remaining cells were sorted for granularity, excluding damaged or clumped
cells, and the presence of GFP, specific for ISCs and EBs. The cells were sorted directly into
RNA extraction buffer (PicoPure RNA isolation kit).
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RNA extraction
For the following procedure all reagents used were part of the Arcturus PicoPure RNA isolation
kit.
After FACS, the sorted cells, in RNA extraction buffer, were incubated in a thermomixer at 42
°C for 1 h. Then 500 µl 70% RNAse free Ethanol was added, mixed well and the solution was
applied to two extraction columns in volumes of 270 µl. The columns were centrifuged 2 min
at 100 g, to bind the RNA, followed by 30 s at 16000g. The flow-through was discarded, 100
µl Wash buffer 1 applied to each column followed by 1 min centrifugation at 8000 g.
Total RNA sequencing
The total RNA sequencing procedures were performed by the „Microarray Core Facility".
Medizinische Fakultät Georg-August-Universität Göttingen, using the Illumina ”sequencing-
by-synthesis” technology.
2.2.8 Maintenance of Drosophila flies
Drosophila stocks were maintained at 21 °C and flipped (transfer of flies into new vials) weekly.
2.2.9 Dissection of Drosophila guts
The flies were anesthetized with CO2 and beheaded. Then the beheaded flies were transferred
on a glass slide with a brush and several drops of PBS-T 0.1% were added on the flies and
a free part of the glass slide on the right of the flies. For dissection each fly was transferred
to the PBS-T 1% covered area on the right. Then the flies were pulled with two precision
forceps between the last abdominal segment and the thorax until the last segment loosens
and the gut, mostly together with the malpighian tubules, comes out to about half of its
length. To prevent rupture of the gut by further pulling, the thorax and the first abdominal
segment were pulled apart revealing the fore-gut and sometimes also the crop. The crop, if
pulled out, would be removed and the gut pulled through the abdomen by pulling of the last
abdominal segment. The obtained gut consists of foregut (together with the proventriculus),
midgut and hindgut (together with the last abdominal segment). The guts were transferred
onto the antibody staining container (Figure 7) using a cut pipette tip preincubated with BSA
to prevent sticking of the guts to the tip. The staining container, consists of the upper part
of a MinElute purification column with the DNA/RNA filter part removed. A metal net was
attached to the bottom by carefully pressing the cut column onto the heated metal net (on a
heating block covered with aluminum foil). The contraption was finally placed into a cut cryo
tube and labeled. The system was developed during the diploma thesis, Roman Petrovsky.
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Figure 7: Staining container
Antibody staining container consisting of a cut MinElute purification column, melted together with a metal net
and a cut cryo tube. (altered picture, diploma thesis, Roman Petrovsky)
2.2.10 Antibody staining of Drosophila guts
For each genotype about 10 guts were dissected and processed according to the following manual
by transfering the guts, in the staining container, from one solution into the next.
- Fixation: 40 min in 0.2% Tween-20, 0.5% Nonidet P40, 8 % Formaldehyde, in PBS
- 1x quick wash in PBS-T
- Permeabilization : over night in 0.5% Saponin, 0.5% Triton-X100, in PBS
- 1x quick wash in PBS-T
- Blocking: 40 min with 5 % BSA in PBS-T
- First antibody: 2 hours or over night, antibody diluted in PBS-T
- 3x quick wash in PBS-T
- 1 hour wash in PBS-T
- Secondary antibody: 2 hours or over night, antibody diluted in PBS-T
- 3x quick wash in PBS-T
- 1 hour wash in PBS-T
2.2.11 Mounting of Drosophila guts
Using a BSA coated pipet tip, guts were transferred on a glass slide and arranged into two
groups of five, top and bottom with the rectum facing upwards /downwards. The PBS-T was
carefully removed and replaced with 20 µl of mounting medium (47,5 % glycerol, 47,5 % PBS, 5
% DABCO). A cover slip (18x18 mm) with 4 spacers of modeling clay, one on each corner, was
placed over the guts and carefully pressed down making contact with the mounting medium.
Controlled doses of pressure were applied onto the four corners, compressing the modeling
clay spacers and equally distributing the mounting medium under the glass slide. To prevent
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evaporation of mounting medium and provide stability, the borders of the cover slip were sealed
by nail polish.
Figure 8: Quantification of midgut stem cell proliferation
All images show inversed gray values of GFP fluorescence aquired by confocal tile scans. Proliferation marked
by GFP positive ”flipout” clones. A: Control with patches of strong (1) and mild to no proliferation (2). B:
control gut, 2 fold magnification, C: Control gut, increased gray values to visualize the structure of the gut. Red
outline marks selected area quantified by mean fluorescence. D: Induced stem cell proliferation activation leads
to near complete population of the gut by GFP positive cells. E: Repression of induced stem cell proliferation,
little to no patches, mostly singe cells.
2.2.12 Quantification of stem cell proliferation
Stem cell proliferation was quantified by measuring the mean GFP fluorescence per gut area.
Tile scans of the respective guts were acquired by confocal imaging. The area of each gut was
outlined using the Fiji ”freehand selection tool”,(Figure 8A, B, C), and the mean fluorescence of
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the selected area determined using the Fiji ”measure” function. Two phenotypes, with varying
amounts of GFP+ cells, were selected to display differences in GFP mean fluorescence values
(Figure 8D and E).
2.2.13 Purification and antibody generaion of Lipin B
The QE80ZZtev Lipin B construct (Table 3) was transformed into BL21. Expression was
induced by 0.5 mM IPTG for 2h at 37 °C. Cells were harvested by centrifugation with 5000
rpm (Heraeus #3057) for 20 min at 4 °C and lysed by microfluidizer. The lysate was centrifuged
at 15000 rpm (Sorvall SS-34) for 15 min and the Supernatant loaded on a His-trap column.
Elution fractions 2-4 were pooled and loaded on a PD-10 desalting column. Desalting fractions
1, 2 and 3 were pooled (2.8 mg/ml protein concentration) and send to ”Charles River” for
generation of antibodies. The received serum was successfully tested for specificity in Flipout
clones expressing Lipin RNAi (Figure44B). During the purification samples from all significant
steps were taken (Figure 9).
Figure 9: Lipin B purification
Scanned SDS-gel of purification samples. Thick band at about 75 kDa marks the expressed Lipin construct. UI:
Uninduced, I: Induced, SN:Supernatant, P: Pellet, Lys: Lysate, FT1/FT2: Flowthrough W: Wash L: Ladder,
(2,3,4): pooled elution fractions, (D1, D2, D3, D4): Desalting fractions
2.2.14 Pseudomonas entomophila infection
100 ml LB-medium + 100 µl Rifampicin were inoculated with Pseudomonas entomophila (P.e.)
bacteria and incubated at 30 °C, over night. The culture was centrifuged at 3466 g for 15 min
and the pellet resuspended in 5 ml PBS + 5 % Sucrose. A small empty fly vial was filled
with a 1 cm layer of small LB-Agar crumbs and about 1,5 ml of P.e./Sucrose solution was
pipetted onto the LB-agar layer, completely covering the Agar pieces. Subsequently a portion
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of the solution was removed, the remaining solution covering only lower levels of the agar layer
but still being accessible to the flies. The upper level of the agar layer was thereby forming a
platform for flies to stand and drink the P.e./Sucrose solution, whilst still being covered by a
layer of P.e., depriving the flies access to a P.e. free source of liquid. A piece of filter paper
also inserted into the vial and attached above the agar layer, without making contact, forming
a platform for flies to rest and clean. To facilitate proper uptake of the solution the flies were
kept without food and water for 16 hours, before being transferred to the prepared vial.
2.2.15 ABT100 treatment
ABT100 was added directly to the cell medium in varying concentrations. Cells were grown on
cover slips and treated with ABT100 for 3 days. ABT100 was added to preheated fly food in
varying concentrations and for different timescales.
2.2.16 Lifespan
Three times 100 flies per genotype (each in a separate small fly cage) were kept in a separate
incubator. Food plates contained either normal fly food or fly food with ABT100, Ru486 or
both. The plates were changed every second day, during the change number of dead flies on
the old plates was noted.
2.2.17 Electron microscopy
To fixate the gut in its natural environment the abdomen of the fly was cut off of the thorax by
use of a micro-scissor and carefully torn on several places to give better access to the fixation
solution. About 8 abdomen were processed in this manner and collected in a 1.5 ml Eppendorf
tube, filled with PBS. The PBS was removed and replaced by fixation solution. The Eppendorf
tube was sealed with parafilm and send to our collaborator, Prof. Georg Krohne, on the same
day.





3.1.1 Role of Dm0 in stem cell signaling
HGPS is a gain-of-function disease caused by the overexpression of a permanently farnesylated
form of Lamin A. As mentioned in section 1.2, among the symptoms of HGPS are a drastically
reduced life span and reduced physical fitness. On a cellular level nuclei of HGPS patients show
nuclear deformations, increased DNA damage and reduced heterochromatin. The Großhans lab
has established a model of HGPS in Drosophila fruit flies. By overexpression of the permanently
farnesylated Lamin Dm0 all of the above mentioned symptoms of HGPS can be observed in
Drosophila. Overexpression of Dm0 in Drosophila midguts reduced the proliferation of ISCs
(Henrick Steffen, bachelor thesis). This result falls into line with the work of other groups,
claiming an involvement of impaired stem cell function in HGPS and ageing [28, 78].
Lamina protein dynamics in the Drosophila midgut
The lamina proteins Dm0, Lamin C and Kugelkern show a distinct dynamics in the Drosophila
midgut. In smaller cell types (ISCs, EBs, EEs) Lamin Dm0 and Kuk show a stronger staining
in comparison to big cell types (ECs). In contrast, lamin C shows weaker staining in small cell
types compared to ECs. Other nucleoplasmic/chromatin bound proteins, like HP1 or nuclear
pore proteins have similar levels in small and big cell types (Figure 10). This difference could
indicate a functional difference in case of Lamin C compared to Dm0/Kuk or redundancy, in
case of Dm0 and Kuk. Since Kuk staining in wildtype flies did show localization at the nuclear
envelope and inside the nucleus at a distinct area, Kuk staining was repeated with a Kuk
deficiency line (pictures right of wildtype Kuk pictures). In the deficiency line the staining at
the nuclear envelope was lost while the staining inside the nucleus remained, proving this type
of staining to be unspecific.
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Figure 10: Dynamics of selected Lamina proteins
A: Overlay of DAPI and a respective lamina protein. Red box marks magnified selection. B: Magnified selection
of the respective lamina protein from A C: Schematic of the dynamics of the respective lamina protein, comparing
protein levels in ISC/EBs and ECs. Kugelkern staining shows localization at the nuclear envelope and at a
distinct area inside the nucleus. Kuk staining in the Kuk deficiency line (pictures on the right of Kuk wildtype
stainings) shows that this is unspecific staining of the Kuk antibody.
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Figure 11: Flipout clonal system
A: Schematic depiction of the genetic mechanism used for ”flipout clones”. Gal4 is expressed under the control
of the ISC/EB specific Esg promoter and is repressed by Gal80TS, under the control of the tubulin promoter.
At 29 °C (high T) Gal80TS is denatured, Gal4 binds to UAS and induces expression of GFP and flippase.
Flippase induces recombinatory flip-out of CD2 thereby putting a second Gal4 allele under the control of the
actin promotor. All daughter cells of the ISC with this recombination event will continue to express Gal4 and
thereby GFP. B: Scheme of flipout-clone induction with confocal images respective to the depicted state of
induction, right. After clonal induction, by shifting flies to 29 °C, only ISCs/EBs are marked by GFP. With
longer time at 29 °C also their daughter cells are marked with GFP and form clones. Altered scheme, initially
created by Jörg Großhans. Scale bar: 25 µm
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Overexpression of Lamin Dm0 has an inhibitory effect on native ISC proliferation
To study the effects of overexpressed Lamina proteins on intestinal stem cell proliferation, the
flipout clonal system [43] was used as a tool to visualize stem cell proliferation over time (Figure
11 A and B). By shifting the flies to 29 °C the temperature-sensitive protein Gal80TS, which
binds and represses Gal4, changes conformation and loses its repressive function. Gal4 is under
the control of the Escargot promoter (Esg), which is specific for ISCs and EBs.
Due to the inhibition of Gal80TS by tempereture shift to 29 °C, Gal4 can bind to Upstream Ac-
tivating Sequences (UAS) which induce expression of GFP and flippase. The expressed flippase
induces recombinatory flip-out of CD2, a gene introduced as a block between the actin pro-
moter and a second Gal4 transgene. With the absence of CD2 and its stop codon, Gal4 is now
additionally expressed under the control of the actin promoter. This marks the time-point of
clonal induction as henceforth not only ISCs and EBs express GFP but also their progeny. The
flip-out system, as described here, is shortened by the term ”EsgTS; FO” where the Escargot-
promoter and the temperature-dependent elements, located on the second chromosome, are
termed ”EsgTS” and the clone-inducing elements on the third chromosome ”FO”, for flip-out.
In addition to GFP, other UAS transgenes can be crossed into the EsgTS; FO background and
will be expressed in the clonal cells. The size of the clonal area can be controlled by the time
the flies are kept on 29 °C (Figure 11 B).
The Drosophila midgut has a natural turnover of about 12 days in females and about 3 weeks
in males [43]. The native proliferative behavior of Drosophila midguts varies strongly in indi-
vidual flies. Sex, age and quality of food play a decisive role. However, after excluding these
factors a distinctive variability remains.
To reproduce and quantify previous results, flip-out clones with and without Dm0 overexpres-
sion, were induced in Drosophila midgut for five days. ISCs in flies expressing Dm0 showed a
strong reduction in clonal area (Figure 12 B) compared to control flies (Figure 12 A). Quan-
tification of mean fluorescence intensity of GFP per gut, indicating the amount of proliferation
(described in subsection 2.2.12) shows a significant reduction in guts overexpressing Dm0 (Fig-
ure 12 C). The level of Dm0 expression was tested by expression in ECs using the EC-specific
Myo promoter to drive Gal4 (Figure 13). Dm0 levels are already significantly increased after
one day of expression,compared to wildtype, and continue to be so after 3 days of expression.
It can be concluded that Dm0 expression was successfully induced in flipout-clones and lead to
a drastic decline in ISC proliferation.
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Figure 12: Dm0 suppresses native proliferation
A: (EsgTS/(Sp/CyO); FO/(Dr/TM3)) Control with about 40 % clonal gut epithelium on average. B: (Es-
gTS/(Sp/CyO); FO/UASt-Lamin Dm0) Lamin Dm0 overexpression leads to a strong reduction of stem cell
proliferation. Due to the strong increase of Dm0 staining in Dm0 overexpressing cells other cells are not visi-
ble in the Dm0 channel. C: Quantification of stem cell proliferation by mean fluorescence/gut, normalized to
control. Clonal induction for 5 days. Scale bar: 25 µm
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Figure 13: Western blot of 1 and 3 day induced myo-GalTS x UAS-Lamin DmO and
OrigonR(wildtype) with Dm0 and α-tubulin costaining
A: 1 day of induction. In the Lamin Dm0 trace a strong additional band can be seen at about (76 KDa), in
comparison to the wildtype (OrR). Another band is in the range of α-tubulin (50 kDa).
B: 3 days of induction. In the Lamin Dm0 trace a clear additional band can be seen at about (76 KDa) and a
band in the range of α-tubulin. The WT trace shows no band in the range of Lamin Dm0 and a strong band
in the range of α-tubulin in an area of indistinct staining. (diploma thesis, Roman Petrovsky)
Lamin Dm0 overexpression does not induce apptosis
To test whether the lack of stem cell proliferation in Dm0 overexpressing guts was due to
induced apoptosis in stem cells, control (Figure 14 A) and Dm0 overexpressing (Figure 14
B) guts were stained with Caspase-3 antibody. The Caspase-3 antibody provided was later
reported to stain the active form and the inactive procaspase (zymogen) form. The staining
proved to be variable in small and big cell types. In both genotypes small cells with (Figure
14-2) and without (Figure 14-1) measurable Caspase levels were present and Caspase levels
had not changed. To test whether the antibody shows a stronger affinity to the active Caspase
form, Maria Kriebel, a PhD student of the Grosshans lab, tested the antibody in wing-imaginal
disks (Figure 14 C and D). In comparison to the control (Figure 14 C), induced apoptosis
by expression of the Reaper protein (Figure 14 D) proved to significantly increase levels of
Caspase 3 staining, compared to the control. Additionally a western blot, provided by the
supplier (Abcam), with the human active form in Lane 1 and the inactive procaspase form in
Lane 2 clearly shows a stronger affinity of the antibody to the active form. Changes in the size
of cells and stained areas are due to natural fluctuations in gut composition, in Caspase low
level background activity and possibly in background activity of the antibody. So it can be
argued, that since Caspase-3 staining of intestinal cells elicits no change in Caspase-3 levels, no
3.1. LAMIN DM0 49
significant alteration of Caspase function was induced by Lamin Dm0.
Figure 14: Caspase levels are not altered by Lamin Dm0 overexpression
A: (EsgTS/(Sp/CyO); FO/(Dr/TM3)) Control, (1) marks small cells with no Caspase staining, (2) marks small
cells with Caspase staining. B: (EsgTS/(Sp/CyO); FO/UASt-Lamin Dm0) Dm0 overexpression with similar
Caspase distributions as control. (1) marks small cells with no Caspase staining, (2) marks small cells with
Caspase staining. 3x enlarged detail of gut-cells in the top (for 1) and bottom right (for 2) of Caspasauthore
channel pictures. C: Oregon R (control) staining of Caspase 3 antibody in wing imaginal disk (courtesy: Maria
Kriebel). D: (MS1096-Gal4; UASt-Reaper) Levels of Caspase 3 staining clearly increase in areas of induced
apoptosis in wing imaginal disks. (courtesy: Maria Kriebel). Clonal induction for 5 days. Scale bar: 25µm
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Figure 15: Notch RNAi overrules inhibition of stem cell proliferation, induced by Lamin Dm0
A: (EsgTS/(Sp/CyO); FO/(Dr/TM3)) Control, B: (EsgTS/Notch-RNAi; FO/(Dr/TM3)) Expression of Notch
RNAi induces strong proliferation of ISCs. Dm0 and DAPI staining shows a dense population of small cell
types. C: (EsgTS/Notch-RNAi; FO/UASt-Lamin Dm0) Overexpression of Lamin Dm0 together with Notch
RNAi does not inhibit stem cell proliferation (C1/C2, 1) or EB differentiation (C2, 2). Clonal induction for 5
days. Scale bar: 25µm
Expression of Notch RNAi can overrule the inhibitory effect of Lamin Dm0
To investigate whether overexpressed Lamin Dm0 permanently inhibits stem cell function,
several ways of inducing proliferation were tested in the Lamin Dm0 overexpression background.
Two ways proved to be successful: the expression of Delta RNAi and Notch RNAi. Both are
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known to induce strong overproliferation in ISCs leading to condensed local accumulations
of small cell types, often referred to as Notch-tumors. The Delta/Notch signaling pathway
controls the identity of ISCs and EBs. Furthermore, it regulates the replenishment of EBs
in case of damage or depletion. ISCs and EBs are known to stay in proximity to each other
forming ISC/EB pairs, with ISCs retainig higher Delta levels, and EB retaining higher Notch
levels. If the ISC senses a reduction of Delta/Notch signaling from its EB partner it will start to
proliferate to replenish the EB until Delta/Notch signaling is reestablished [65, 66]. So if Delta
or Notch are knocked down in ISCs a loss of its EB partner is simulated, inducing continuous ISC
proliferation. This proliferation is known to be mediated by autocrine EGFR signaling in the
initial stage of the tumor and it is further increased when the proliferating ISCs push ECs out of
the epithelium and induce their apoptosis. ECs then secrete cytokines which induce JAK/STAT
signaling in ISCs increasing their proliferation [71]. By expressing Notch RNAi in flip-out clones
the described effect was reproduced (Figure 15 B). DAPI and Lamin Dm0 channels show a
dense accumulation of small cell types (Figure 15 B1). However clones also were comprised of
differentiated ECs (Figure 15 B, 2). By overexpressing Lamin Dm0 in the background of Notch
RNAi induced proliferation, a mild reduction of proliferation was observed (Figure 15 C1 and
C2). Guts still harbour pockets of intense local proliferation (Figure 15 C1/C2, 1) but also show
differentiated ECs (Figure 15 C2, 2); so the ability of enteroblasts to differentiate was not altered
by Dm0 overexpression. The reduction in proliferation could possible result from inhibition
JAK/STAT signaling since initial proliferation of ISCs in Notch-tumors requires autocrine
EGFR signaling and the occurrence of tumors was not noticeable reduced but rather their size.
However quantification of this effect is difficult since tumors of a certain size would naturally
merge and thereby render indistinguishable. Since wildtype Notch-tumors are bigger they would
more often form islands of GFP positive cells likely formed of several initial Notch-tumors.
The results indicate that Dm0 expression does not permanently harm ISCs or inhibit their
proliferative function. Nor does Dm0 permanently inhibit differentiation.
Tested signaling pathways
As ISC proliferation is dependent on a set of signaling pathways [48, 43, 81, 89] it is conceivable
that Dm0 might elicit its repressive effect on ISC proliferation by negatively affecting signaling
pathway components. Activating each signaling pathway and coexpressing the activator with
Dm0 could reveal which pathway would be affected by Dm0 overexpression. Several known
activators of ISC proliferation were expressed in flip-out clones and their potential to induce
ISC proliferation was assessed (Figure 16). The expression of a constitutively active form
of Hopscotch (HopTuml) or UPD (both activators of the JAK/STAT signaling pathway) and
induction of Warts RNAi (activating the Hippo pathway) showed a significant increase in ISC
proliferation and will be addressed in following chapters.
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Figure 16: Tested activators of signaling pathways involved in ISC proliferation
Scheme lists known signaling pathways involved in ISC proliferation and highlights pathway activators (red
box and text) that were tested in flipout clones. Tested pathways (simplified) from left to right: EGF/EGFR,
Hippo, Jak/Stat, Dpp (BMP), Wnt (canonical).
Induction of Mad RNAi (leading to downregulation of the BMP pathway that inhibits ISC
proliferation) and APC1 RNAi (activating Wnt signaling) did not result in a significant increase
in ISC proliferation (Figure 16, Figure 17 B and C). Therefore, since activation of the DPP
and Wnt pathway was unsuccessful, a potential effect of Dm0 on these pathways could not be
tested. However since all mentioned pathways are reported to drive native ISC proliferation it
can be argued that Dm0 is at least able to inhibit Dpp and Wnt-induced proliferation in an
unchallenged situation (Figure 12). Expression of HopTuml lead to a significant increase in ISC
proliferation (Figure 17 D) but could not be utilized to test for the inhibitory effect of Dm0
because a fly stock with HopTuml and Lamin Dm0 transgenes was lethal at the larval stage.
Lamin Dm0 inhibits Warts RNAi induced stem cell proliferation
Warts RNAi was induced in flip-out clones without and with Dm0 coexpression (Figure 18
B/C). Warts RNAi alone lead to a significant increase in proliferation (Figure 18 B) and increase
in small cell types (Figure 18 B, 1). However, the effect was not as strong as UPD-induced
proliferation (shown later). Co-induction of Warts RNAi with Dm0 lead to a drastic decrease of
clonal ISC proliferation (Figure 18 C). Quantification shows that Warts RNAi induced increase
in proliferation and its suppression by Dm0 coexpression is significant. (Figure 18 D).
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Figure 17: Tested signaling pathway activators
A: (EsgTS/(Sp/CyO); FO/(Dr/TM3)) Control, B: (EsgTS/Mad-RNAi; FO/+) No significant increase in prolif-
eration compared to control. C: (EsgTS/APC1 -RNAi; FO/+). No significant increase in proliferation compared
to control. D: (EsgTS/HopTuml; FO/+). Significant increase in proliferation after 4 days of proliferation com-
pared to control. Clonal induction for 5 days for A, B, C. Scale bar: 25µm
Lamin Dm0 inhibits UPD-induced stem cell proliferation
Expression of UPD in flipout clones lead to a strong over-proliferation event with nearly com-
plete coverage of gut area by clonal cells within 5 days (Figure 19 B). Dm0 and DAPI staining
also shows an increased number of small cell types (Figure 19 B, 1) and higher cellular density.
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Figure 18: Dm0 suppresses Wts RNAi induced proliferation
A: (EsgTS/(Sp/CyO); FO/(Dr/TM3)) wildtype, B: (EsgTS/UAS-Warts-RNAi; FO/(Dr/TM3)) Expression of
Warts-RNAi greatly increases ISC proliferation and leads to an increased number of small cell types (1) C:
(EsgTS/Warts-RNAi; FO/UASt-Lamin Dm0) Dm0 coexpression with Warts RNAi overrules the proliferation
signal and reduces ISC proliferation to about 50% of WT-levels. D: Quantification of stem cell proliferation by
mean fluorescence/gut, normalized to control. Clonal induction for 5 days. Scale bar: 25µm
Upon Dm0 overexpression UPD-induced proliferation was reduced drastically (Figure 19 C)
similar to levels present in sole Dm0 overexpression (Figure 19 D). Detail box in Dm0 and
GFP staining pictures shows increased Dm0 staining in clonal cells versus non clonal cells upon
UPD and Dm0 overexpression (Figure 19 C) and very strong Dm0 staining in clonal cells versus
non clonal cells upon overexpression of Dm0 (Figure 19 D), compared to wildtype and UPD
overexpressing cells (Figure 19 A and B). Quantification shows that the UPD induced increase
in proliferation is highly significant. Also reduction of proliferation upon coexpression of Dm0
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and UPD is highly significant and similar in strength as Dm0 expression alone (Figure 20).
Figure 19: Dm0 suppresses UPD induced stem cell proliferation
A: (EsgTS/(Sp/CyO); FO/(Dr/TM3)) Wildtype, B: (EsgTS/UASt-UPD; FO/(Dr/TM3)) Expression of UPD
leads to a strong overproliferation event with increased numbers of small cell types (1) and cellular density. C:
(EsgTS/UASt-UPD; FO/UASt-Lamin Dm0) In coexpression with UPD Dm0 inhibits ISC proliferation similar
to levels present in sole Dm0 overexpression (D). D: (EsgTS/(Sp/CyO); FO/UASt-Lamin Dm0) Lamin Dm0
overexpression leads to a strong reduction of stem cell proliferation. 3x enlarged detail of gut-cells in the top
right of Dm0 staining pictures shows clonal and non clonal cells with varying degree of Dm0 staining. Clonal
induction for 5 days. Scale bar: 25µm
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Figure 20: Dm0 supresses UPD induced stem cell proliferation
Quantification of A, B, C, D. Increase in proliferation upon UPD expression and decrease of proliferation upon
Dm0 overexpression are significant (p-value < 0,0001).
Lamin Dm0 and Stat levels are anti-correlated in enterocytes
To test whether Dm0 directly or indirectly affects the JAK/STAT pathway or whether it
inhibits proliferation pathway independently, antibody staining against the active form of Stat
(pStat) was applied to previously processed phenotypes. Increased Stat staining in wildtype
applies mostly to patches of cells which do not stringently correlate with clones. Overexpression
of UPD-expressing clones clearly correlates with an increase in pStat levels compared to non
clonal areas (Figure 21 B). Coexpression of Dm0 with UPD reduces stat levels in nearly all
clonal cells (Figure 21 C, 1) while non clonal cells show an increase in Stat levels. In clones
with sole Lamin Dm0 expression pStat staining is absent in the majority of cells (Figure 21 D,
1) but still present in far more cells (Figure 21 D, 2) as in UPD/Dm0 co-expressing clones.
To test whether Lamin Dm0 acts differently on Stat than on pStat levels, a co-staining with
both antibodies was made (Figure 22). Both antibodies showed a high similarity in their
specificity in clonal and non clonal cells. Increase in Stat levels in a particular cell did directly
translate into increased pStat levels.
The pStat reducing effect of Dm0 in clones co-expressing UPD could be reproduced with Stat
staining and was quantified (Figure 23). Overlay of Dm0 and GFP staining serves as a control
(Figure 23 A). Quantification of nuclei with high GFP staining vs. nuclei with high Dm0
staining shows a positive correlation as cells with GFP also overexpressed Dm0 (Figure 23
D). Fluorescence levels of Dm0 and Stat staining however are anti-correlated (Figure 23 C)
indicating a direct or indirect effect of Dm0 on Stat levels.
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Figure 21: pStat levels are downregulated in Dm0 expressing cells
A: (EsgTS/(Sp/CyO); FO/(Dr/TM3)) Wildtype with variable pStat staining in clonal and non clonal cells.
B: (EsgTS/UASt-UPD; FO/(Dr/TM3)) Expression of UPD leads to strong overproliferation. pStat staining
is strongly increased in clonal compared to non clonal cells. C: (EsgTS/UASt-UPD; FO/UASt-Lamin Dm0)
In coexpression with UPD Dm0 inhibits ISC proliferation similar to levels present in sole Dm0 overexpression.
pStat levels are considerably lower in clonal cells but variable in non clonal cells. (D). D: (EsgTS/(Sp/CyO);
FO/UASt-Lamin Dm0) Lamin Dm0 overexpression leads to a strong reduction of stem cell proliferation. pStat
staining is variable in clonal and non clonal cells. (1) marks clonal cells with reduced pStat staining, (2) marks
clonal cells with regular stat staining. 3x enlarged detail of gut-cells in the top right of Dm0 and Stat staining
pictures shows clonal cells with low Stat staining, the box on the low right shows clonal cells with strong Stat
staining. Clonal induction for 5 days. Scale bar: 25µm
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Figure 22: pStat and Stat show equal distribution
A: (EsgTS/(Sp/CyO); FO/(Dr/TM3)) Wildtype shows no difference in clonal vs non clonal cells is visible in
pStat or Stat staining. Both forms are closely correlated in all cells. B: (EsgTS/UASt-UPD; FO/(Dr/TM3))
Expression of UPD leads to a dramatic increase in pStat and Stat staining in nearly all clonal cells. pStat and
Stat levels are highly correlated. Green outline marks non clonal cells that show less Stat staining in comparison
to clonal cells. C: (EsgTS/UASt-UPD; FO/UASt-Lamin Dm0) Dm0 coexpression with UPD leads to a clear
decrease of pStat and Stat levels in clonal cells. D: (EsgTS/(Sp/CyO); FO/UASt-Lamin Dm0) Comparison of
pStat and Stat antibody staining in Dm0 expressing clones shows no significant difference between both forms.
In both cases clonal and non clonal cells show variation in staining. Red outline marks clonal cells, green outline
marks non clonal cells. 3x enlarged detail of gut-cells in the top right of Dm0 and Stat staining pictures shows
examples clonal cells in A, C and D and non clonal cells in B. Clonal induction for 5 days. Scale bar: 25µm
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Figure 23: Levels of Dm0 and Stat are anti-correlated
A: (EsgTS/UASt-UPD; FO/UASt-Dm0) Color overlay of GFP and Dm0 staining. B: (EsgTS/UASt-UPD;
FO/UASt-Dm0) Color overlay of Stat and Dm0 staining C: Quantification of fluorescence levels of GFP and
Dm0 in individual cells indicated anticorrelation. D: Quantification of fluorescence levels of Stat and Dm0 in
individual cells indicated positive correlation.
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Lamin Dm0 acts downstream of Stat
To determine at which step of the pathway Dm0 inhibits the proliferation signal of the JAK/STAT
signaling, Dm0 was co-expressed with a constitutively active form of Stat, Stat∆N∆C (Figure
24) [26]. In this instance the JAK/STAT dependent proliferation is induced downstream of
Stat, thereby the upstream factors UPD, Domeless and Hopscotch can be taken out out of
the equation. Expression of Stat∆N∆C only resulted in a mild, insignificant increase in clonal
area (Figure 25 B, Figure 26). However the fact that the vast majority of clonal area is de-
void of regular Stat staining (Figure 25 B Stat channel) indicates the presence of Stat∆N∆C
which probably reduced normal Stat levels in clones by a negative feedback loop. Furthermore,
cells in the vicinity of clones show increased levels of normal Stat. This could minimize the
effect of Stat∆N∆C to increase clonal area by ISC proliferation as non clonal areas would com-
pete for gut surface-area due to induced ISC proliferation. Dm0 over-expression together with
Stat∆N∆C again lead to near complete arrest of ISC proliferation (Figure 25 C, Figure 26).
Levels of Stat in clones also remain reduced similar to Stat∆N∆C expression alone, indicating
the presence of Stat∆N∆C displacing Stat. Dm0 expression alone (Figure 25 D) reduces ISC
proliferation slightly more than in coexpression with Stat∆N∆C (Figure 26) but clonal cells
show higher levels of Stat, compared to (Figure 25 C) indicating that Dm0 does not noticeably
reduce native levels of Stat.
Figure 24: Stat∆N∆C
Scheme shows Jak/Stat pathway components. Stat∆N∆C activates the JAK/STAT pathway at the level of
Stat. Red arrows indicate possible interaction with Dm0
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Figure 25: Dm0 supresses proliferation induced by Stat∆N∆C
A: (EsgTS/(Sp/CyO); FO/(Dr/TM3)) Control, B: (EsgTS/UAS-Stat∆N∆C; FO/(Dr/TM3)) Expression of
Stat∆N∆C does only induce mild proliferation. Stat staining is increased in non clonal areas and
decreased in clonal areas. C: (EsgTS/UAS-Stat∆N∆C; FO/UASt-Dm0) Dm0 in coexpression with
Stat∆N∆C significantly reduced ISC proliferation. Stat staining is increased in non clonal areas
and decreased in clonal areas. D: (EsgTS/(Sp/CyO); FO/UASt-Dm0) Dm0 expression significantly reduces
ISC proliferation but does not reduce Stat levels in clones. 1: Marks clonal cells without Stat staining. 2:
Marks clonal cells with Stat staining. Red lining the Stat channel indicates clonal areas. Clonal induction for
5 days. Scale bar: 25µm
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Figure 26: Dm0 supresses proliferation induced by Stat∆N∆C
Quantification of stem cell proliferation by mean fluorescence/gut, normalized to control. No significant increase
in proliferation was recorded in guts expressing Stat∆N∆C, but a significant downregulation upon coexpression
of Dm0 and Stat∆N∆C.
Lamin Dm0 does not act on dMyc
dMyc, the Drosophila homologue of the oncogene Myc, has been reported to act downstream
of the JAK/STAT, Hippo and EGFR pathway and mediate their function [74](Figure 27 A).
According to previous results, the inhibitory effect of Dm0 overexpression on ISCs can overrule
the proliferative signals of both the JAK/STAT and the Hippo pathway. Therefore it is unclear
whether Dm0 acts downstream of both pathways on the level of dMyc. To address this question
dMyc antibody was used to compare control and Lamin Dm0 overexpression phenotypes (Figure
27 B and C). dMyc staining reveals no change in Dm0 overexpressing clonal cells, indicating
no effect of Dm0 on dMyc. However dMyc staining was homogeneous throughout the wildtype
gut. This however would have been expected since Stat levels did show significant variation
in intestinal cells correlating with potential areas of proliferation (Figure 25 A, Figure 21 A).
In the cited paper [74] however only situations of induced proliferation were displayed to have
raised dMyc levels. Levels of the dMyc antibody staining occurring in a native, uninduced
situation of proliferation were not discussed.
3.1.2 Cell cycle control
To test whether Dm0 expression affects the cell cycle, the fly-FUCCI construct [95] was used
to map cell cycle stages of wildtype and Dm0 expressing ISCs/EBs. The FUCCI system uses
E2F1 fused GFP and Cyclin B fused RFP to track different cell cycle stages (Figure 28A).
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Figure 27: dMyc levels are not altered by Lamin Dm0 overexpression
A:Scheme of the signaling pathways upstream of dMyc shows the JAK/STAT, Hippo and EGFR path-
ways activating dMyc downstream which in turn mediates the proliferation response. B: (EsgTS/(Sp/CyO);
FO/(Dr/TM3)) Control, No changes in dMyc were visible in potential areas of proliferation. Red lining marks
GFP positive flipout clones. C: (EsgTS/(Sp/CyO); FO/Dm0) dMyc levels are not altered in Dm0 overexpress-
ing cells. Red lining marks GFP positive, Dm0 overexpressing flipout clones. 3x enlarged detail of gut-cells in
the top right of dMyc staining pictures. Scale bar: 25µm
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This system was tested in flies expressing the same transgenes as EsgTS but without
the UAS-GFP. E2F1-GFP and CyclinB-RFP (UAS-FUCCI) expression is induced by Esg-
Gal4/UAS-FUCCI; Gal80TS/(UASt-Dm0 or TM3). So with this system the cell cycle stages
of ISCs and EB can be tracked with or without Dm0 expression. Since this is not a clonal
system only ISCs and EBs are marked with E2F1-GFP and CyclinB-RFP. We successfully
expressed the FUCCI construct in ISCs/EBs and were able to track the cell cycle of those cell
types specifically (Figure 28 A/D). Expression of FUCCI without Dm0 resulted in a majority
of cells in G2 phase, a small group of cells in G1 and no cells in S phase (Figure 28 B, 29 A
and C). Expression of FUCCI with Dm0 also resulted in a majority of cells in G2 phase but
no G1 population of cells. Instead a small population of cells showed S phase staining (Figure
28 C, 29 B and C). Therefore Dm0 decreases the number of G1 cells and leads to an increase
of cells in S and G2 phase compared to wildtype.
Figure 28: The fly-FUCCI system
A: Schematic of the FUCCI system. GFP alone marks cells in G1 phase, RFP alone marks cells in S phase and
both GFP and RFP mark cells in G2 phase. Scheme adopted from[95]. B: Color overlay of E2F1-GFP/Cyclin-B-
RFP in ISCs/EBs in wildtype. C: Color overlay of E2F1-GFP/Cyclin-B-RFP in ISCs/EBs with Dm0 expression.
1 marks cells with only E2F1-GFP, 2 marks cells with E2F1-GFP and Cyclin-B-RFP, 3 marks cells with only
Cyclin-B-RFP. D: Exemplary cells from B and C for each cell cycle stage, 4x enlarged. Scale bar: 25µm
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Figure 29: Dm0 alters the cell cycle
A: (Esg/FUCCI; TS(-GFP)/+) Expression of FUCCI in wildtype. B: (Esg/FUCCI; TS(-GFP)/Dm0) Expres-
sion of FUCCI and Dm0. 1 marks cells with only E2F1-GFP, 2 marks cells with E2F1-GFP and Cyclin-B-RFP,
3 marks cells with only Cyclin-B-RFP. Scale bar: 25µm C:Quantification of percent of wildtype or Dm0 ex-
pressing cells in G1, S and G2 phase. In wildtype cells about 77 % of cells are in G2 and about 23 % in G1
phase. In Dm0 expressing cells about 87 % of cells are in G2, 12 % in S and 1% in G1 phase.
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Figure 30: Dm0 has no effect on nuclear transport (Picture provided by Michaela Clever)
A: Kc167 cells 48h after transfection with RFP-NES. B: Kc167 cells 48h after transfection with RFP-NES and
Dm0. C: Quantification of measured nuclear/cytoplasmic ratios in Kc167 cell 24h and 48h after transfection
with RFP-NES or RFP-NES + Dm0. No significant difference between cells expressing Dm0 and control cells
was measured.
3.1.3 Lamin Dm0 overexpresssion has no effect on nuclear
transport behavior
One way how Dm0 could affect the proliferative behavior of ISCs is by altering the cell’s
nuclear/cytoplasmic transport. This has been reported to be the case for Progerin [46], so
naturally it was tested whether Dm0 expression would alter transport behavior. Dr. Michaela
Clever, a member of the Großhans group, and myself conducted several experiments to test
for altered transport behavior upon Dm0 or Kuk expression. Expression of RFP fused with
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a nuclear export signal (NES) and a nuclear localization sequence (NLS) in Drosophila Kc167
cells would provide the means to detect altered transport behavior as the ratio of nuclear
vs cytoplasmic RFP would be altered (Figure 30 A). The cells show RFP staining in the
nucleus because NLS and NES sequences establish an import/export balance which lies on
the import side. However upon Dm0 expression no change in the nuclear/cytoplasmic ratio
was detectable (Figure 30 B). Quantification of the nuclear/cytoplasmic ratio 24 hours and 48
hours after transfection did not show a significant difference between cells with and without
Dm0 expression.
3.2 Gene expression of Dm0 overexpressing ISCs/EBs
Previous experiments have indicated an involvement of Dm0 in the JAK/STAT pathway down-
stream of Stat but the exact mechanism in which Dm0 acts remained elusive. It could be
directly affecting the Stat transcription factor by binding to it, or indirectly by acting on the
downstream targets of Stat which, via a negative feedback loop, downregulate upstream targets
[7]. To answer that question and shed light on how Dm0 might affect other cellular processes
a total RNAseq experiment was initiated. Since ISCs are the sources of proliferation in the
intestine and Dm0 inhibits proliferation it is conceivable that the focus of transcriptome alter-
ations, in this experiment, is on ISCs. Therefore no flipout cassete was used to mark daughter
cells. This way the effects of UPD and Dm0 overexpression on the transcriptome are observed
in ISCs/EBs exclusively.
Four phenotypes were compared in this experiment: 1. EsgTS/CyO; Dr/TM3 (control)
2. EsgTS/(Sp/CyO); Dm0/(Dr/TM3) (Dm0 overexpression) 3. EsgTS/UPD; Dr/TM3 (UPD
expression, induction of ISC proliferation) 4. EsgTS/UPD; Dm0/(Dr/TM3) (UPD expression
together with Dm0). The expression profile of Phenotypes 2, 3, 4 were compared to the control
(1) to find candidates of genes which were significantly increased or decreased in expression.
To simplify their labeling short terms for each comparison were formed: Control vs UPD for
EsgTS/CyO, Dr/TM3 versus EsgTS/UPD; Dr/TM3, Control vs Dm0 for EsgTS/CyO;Dr/TM3
versus EsgTS/(Sp/CyO); Dr/Dm0 and Control vs UPD+Dm0 for EsgTS/CyO; Dr/TM3 versus
EsgTS/UPD; Dr/Dm0. So UPD for instance is the shortened term for genes that showed a
significant increase in expression in the EsgTS/UPD;Dr/TM3 sample compared to the control
sample EsgTS/CyO; Dr/TM3.
In the UPD sample 374 candidates showed decreased expression of less or equal than 50%
(log2 < = -1) and 224 candidates showed increased expression of more than 200% (log2 >=
1). The numbers for all significantly up or downregulated candidates are displayed in Table 6.
A collection of the 30 highest up and downregulated transcripts, for each group, is displayed
in the appendix.
68 CHAPTER 3. RESULTS
Table 6: Results
Sample log2 fold change <= -1 log2 fold change >= 1 total
Control vs UPD 374 224 598
Control vs Dm0 1027 673 1700
Control vs UPD + Dm0 778 710 1488
Dm0 expression induces notch expression and affects the JAK/STAT receptor
domeless.
Upon analysis of the RNAseq data the transcript collection was screened for candidates involved
in ISC proliferation regulating signaling pathways, apoptosis and cell cycle. A selection of
affected transcripts is displayed in table 7, transcripts significantly upregulated are marked
by 1 (log2 >= 1), transcripts significantly downregulated are marked by -1 (log2 <= -1).
The validity of the experiment was confirmed by the expression pattern of UPD1 and Dm0.
UPD1 transcripts that were significantly increased in samples UPD and UPD + Dm0 and Dm0
transcripts were significantly increased in samples Dm0 and UPD + Dm0.
Transcripts for JAK/STAT pathway receptor domeless are upregulated in the UPD expressing
sample while during coexpression of Dm0 and UPD the transcript levels are normalized. Upd2
transcripts are downregulated upon UPD1 overexpression. Notch transcripts are upregulated
in all three samples.







upd1 1 0 1
Lam (Dm0) 0 1 1
dome 1 0 0
upd2 -1 0 0
N (Notch) 1 1 1
Lamin Dm0 can reduce or revert the expression of about half of the genes
activated or downregulated by UPD expression
Expression of UPD lead to the upregulation of 224 transcripts and downregulation of 374
transcripts, compared to the control. Since Dm0 has shown to inhibit the JAK/STAT pathway
the question whether this inhibition is specific or not has to be addressed. Upon coexpression
of UPD and Dm0 about half of the transcripts, differentially expressed upon UPD expression,
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did show a normalized or reversed expression (Figure 31). This indicates that Dm0 acts on
the JAK/STAT pathway in a specific manor since a random chance of altering these genes is
highly unlikely.
Figure 31: RNAseq Results
Schematic shows the number of transcripts that were significantly up/downregulated upon UPD expression
compared to the control (shown by arrows pointing to red/blue bar for up/downregulation). About 50 % of the
same transcripts were normalized upon Dm0 coexpression with UPD (right side).
GO annotation
For gene ontology (GO) annotation gene IDs with significant up or downregulation (log2 <
-1 or >1) of transcripts were analysed with the Database for Annotation, Visualization and
Integrated Discovery (DAVID ) v6.8 website. DAVID allows the classification of gene IDs with
respect to the biological process, cellular compartment or molecular function they might be
involved in. For each of the three options gene IDs are classified into subcategories. For each
subcategory the count of gene IDs is given together with other factors that eventually form the
false discovery rate FDR. The false discovery rate gives an estimate on how likely the correct
classification is. For easier display of small and big values the negative decadic logarithm of
the FDR (-log10(FDR)) is used, so a low FDR results in a high (-log10(FDR)), indicating high
likelihood of correct categorization. All (-log10(FDR) values above 1 have a FDR lower than
10%, above 2, lower than 1% etc.
It is likely that certain geneIDs are found in several subcategories and that some will not be
allotted to a subcategory. Therefore the sum of all geneID counts will not represent the number
of geneIDs submitted to the DAVID website. Also if several geneIDs of say downregulated
transcripts are found in a certain subcategory, E.g. proteolysis, no definite conclusion about
the effect on proteolysis can be made, since it could be all transcripts of either positive or
negative-regulating pathway components.
GO-annotations were created for Control vs: Dm0, UPD and UPD+Dm0 (terms explained
in the beginning of section 3.2).
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Figure 32: GO annotation of transcripts altered by Dm0 expression
List of GO annotations of transcripts whose levels were significantly altered by Dm0 overexpression, compared
to the control. A: GO annotation of upregulated transcripts, upon Dmo overexpression. B:GO annotation of
upregulated transcripts, upon Dmo overexpression. -Log10(FDR) is the negative decadic logarithm of the false
discovery rate. It gives an estimate about the level of trustwothines of transcripts faling in a certain category.
Numbers bigger than 1 have a lower FDR than 10%, higher than 2 equals lower than 1%. Numbers in brackets
after the respective term signify the number of gene IDs in that category. A higher number means that more
genes in that category are affected by Dm0 overexpression.
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Since each comparison (E.g. Control vs Dm0) was divided into upregulated and down-
regulated transcripts and each group was tested with respect to biological process, cellular
compartment or molecular function, 6 different GO annotations were created for each compar-
ison. Resulting in a total of 18. As an example only the biological processes affected by Dm0
are displayed in this chapter (Figure 32), the complete set is listed in the appendix (Table 18
to 35).
Dm0 overexpression resulted in a significant increase of transcripts involved in several as-
pects of DNA repair and modulation , as well as hippo pathway signaling and protein stability
(Figure 32 A, Table 18). Accordingly most counts are located in the categories of nucleus
and nucleolus in ”cellular compartment” (Table 19) and in DNA/nucleic acid associated pro-
cesses in ”molecular function” (Table 20). On the other hand Dm0 overexpression lead to
reduction of transcripts involved in proteolysis, reduction of oxidation and neuronal regulation,
among others (Figure 32 B, Table 21). This correlated with mostly membrane associated cat-
egories in ”cellular compartment” (Table 22) and categories involved with peptidase activity,
anti-oxidation (E.g. glutathion metabolic process) and neuropeptide regulation in ”molecular
function” (Table 23).
Overexpression of UPD did not result in upregulation of transcripts involved in categories of
apparent significance (Table 24), however similar to Dm0 overexpression, in a downregulation
of transcripts involved in proteolysis and oxidation reduction (Table 27). Accordingly, similar
to Dm0 overexpression, categories with membrane associated localization are listed in ”cellular
compartment” and peptidase as well as glutathion activity in ”molecular function” (Table
28/29).
Upon overexpression of Dm0 and UPD together a mixture of subcategories originally found
in either sole Dm0 or sole UPD expression and several new subcategories are listed in ”biological
process” for upregulated transcripts (Table 30). One subcategory from sole UPD overexpres-
sion remained , dopamine uptake involved in synaptic transmission. And several subcategories
involved with DNA repair/modulation remained from sole Dm0 overexpression. New subcate-
gories involve mostly unrelated processes, proteolysis is the one with the most geneID counts
but also with the highest FDR. In a similar fashion ”cellular compartment” and ”molecular
function” display a mix of subcategories from the sole expression of UPD and Dm0 with some
new subcategories (Table 31/32). For downregulated transcripts, upon Dm0 and UPD overex-
pression, in ”biological process” also a mixture of subcategories from each sole Dm0 and UPD
overexpression and some new subcategories was listed (Table 33). Important subcategories that
remained were proteolysis and oxidation reduction from both sole Dm0 and UPD and DNA re-
pair/remodeling from Dm0. New subcategories with a low FDR were flavonoid glucoronidation
and flavonoid byosynthetic process. Categories in ”cellular compartment” and ”molecular func-
tion” (Table 34/35) are mixed in a similar fashion and respective to their correlating category
in ”biological process”.
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Table 8: Overlap of candidates, induced by Dm0 expression, with LADs
log2 <= -1 log2 >= 1 all transcripts
Control vs Dm0 +
LADs
337 200 + LADs 1044
Control vs Dm0 -
LADs
606 369 - LADs 1893
total 943 569 total 2937
C. vs Dm0 +
LADs/total (%)
35.7 % 35.1 % in LADs/ total
(%)
35,6 %
Expression of genes in lamina associated domains is not altered preferentially by
Dm0 overexpression
Genome regulation has previousy been associated with lamina associated domains (LADs) [55].
To test whether genes that are located in LADs are affected more by Dm0 expression than genes
outside of LADs a list of known LADs was compared to transcripts significantly up or downreg-
ulated by Dm0 in comparison to the control. Of transcripts whose coding region lies in LADs
337 transcripts were significantly downregulated and 200 transcripts significantly upregulated
(Table 8 Control vs Dm0+LADs). Transcripts whose coding region lies outside of LADs 606
transcripts were significantly downregulated and 369 transcripts significantly upregulated (Ta-
ble 8 Control vs Dm0-LADs). That results in a ratio of 35.7% of genes that are downregulated
upon Dm0 expression and lie in LADS and a ratio of 35.1 % of genes that are upregulated upon
Dm0 expression and lie in LADs. However, comparison of all transcripts that were significantly
up or downregulated in any of the tested genotypes and were located in LADs (+LADs), with
all transcripts that were not located in LADs (-LADs, did result in a ratio of 35.6 % of all
transcripts that lie in LADS. This shows that the ratio of transcripts with coding regions in
LADs and outside of LADs did not change in transcripts differentially expressed upon Dm0
overexpression. Also no change in the ratio of transcripts whose levels were increased versus
transcripts whose levels were reduced,upon Dm0 overexpression, was noted.
Comparison of JAK/STAT targets with other studies
The expression of UPD caused a significant change of expression in 598 candidate genes. To
test whether these candidates are typical JAK/STAT target genes they were compared with the
results from two other groups. The first study, by the Martin Zeidler lab, used transcript pro-
filing of Drosophila haemocyte-like cells (Kc167) where JAK/STAT signaling was induced with
UPD conditioned medium [6]. The second study, by the lab of Erika Bach, did a genome-wide
bio-informatics search for genes with Stat92E binding sites [30].
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Figure 33: Comparison of JAK/STAT target studies
Schematic of the transcriptional target overlap of three different Studies. This work used ISCs/ EBs and
activated JAK/STAT signaling by UPD1 expression. Bina et al. 2010 did a transcript profiling approach of
Drosophila haemocyte-like cells and induced Jak Stat signaling by UPD in the medium. Flaherty et al. 2009
did a genome-wide bio-informatics search for genes with Stat92E binding sites. In this work 598 candidate genes
were found that showed an overlap of 76 genes with the set of Flaherty et al. and 55 genes with Bina et al. In
comparison the sets of Bina et al. and Flaherty et al. show an overlap of 188 candidates. Only 8 candidate
genes did show an overlap with all tree studies.







overlap candidates 55 76 188




random overlap in % 2.4 2,6 4,1
overlap in % /
random overlap in %
1,35 1,38 1,72
While Bina et al. 2010 did show an overlap of 55 candidates with this work and Flaherty
et al. did show an overlap of 76 candidates, both studies did show an overlap of 188 candidate
genes. Since both studies have more candidates they also have a higher statistical chance of
overlap. Only 8 genes were found in all three studies (Figure 33). So the overlap of candidates
is relatively small, only 3,6 % in this work and Flaherty et al. 2009, 3,2 % in this work and Bina
et al. 2010 and 7,3 % in Flaherty et al. and Bina et al. This indicates that the JAK/STAT
downstream target genes are quite divers and differ greatly in different tissues (Table 9 ”overlap
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in %”). However, the percentage of overlap is higher than a purely random chance of overlap by
the same numbers of genes, in all three cases (Table 9 ”random overlap in %”). This amounts
to a 35% higher overlap than by random chance comparing this work and Bina et al., 38%
higher overlap comparing this work and Flaherty et al. and 72% higher overlap comparing
Flaherty et al. and Bina et al. (Table 9 ”overlap in % / random overlap in %”).
3.3 Lamin function
The role of Dm0 in Drosophila intestinal cells is not well understood. To understand the
function of Dm0 for ISC proliferation and its effect on other nuclear and cell cycle components
the Dm0 null mutant LamD395 was used in combination with the MARCM clonal system
(Figure 35). MARCM uses the Gal4/ Gal80 system in combination with the Flp/FRT system.
In the Gal4/Gal80 system, Gal4 is repressed by Gal80 and prevents Gal4 binding to UAS
(upstream activating sequence) enhancer sites. When Gal80 is removed Gal4 can bind to UAS
enhancer sites and induce the expression of a transgene, in this case GFP. In the Flp/FRT
system a flippase mediates the recombination of cromatids at specific FRT recombination sites
(FRT: flippase recognition target ). Combined the MARCM system shows the presence of
a homozygous mutant chromatid in a cell by the absence of the, Gal80 expressing, wildtype
chromatid and henceforth expression of GFP. Therefore cells that are homozygous mutant will
be marked by GFP. As control a wildtype chromatid with the FRT recombination site is used,
creating wildtype clones with GFP expression.
Figure 34: Molecular characterization of null allele lamD395 (picture from [62])
Schematic of the LMNA locus. Exons are presented as large grey arrows. LamP marks the P-element insertion
site.∆395 bar indicates the range of the lamD395 P-element excision.
The Lamin D395 null mutant was generated by a P-element mediated deletion of the second
exon, containing the translation start codon (Figure 34 A). This lead to a complete loss of the
Dm0 protein [62]. A survival screen demonstrated a 41% mortality during larval stage, 58%
during pupal stage and 1% escapers [62]. This indicates a significant yet not absolutely essential
role during larval and pupal development. Using the same mutant another group found a role
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for Dm0 in the testis of the adult fly [18]. Another work using a different null allele reported
no change in proliferation behavior in larval development, no change in nuclear shape and
chromosomal structure [67]. No such characterization of Dm0 had been implemented in the
adult midgut therefore several aspects such as potential changes in heterochromatin, cell cycle,
proliferation or in Lamin C levels are addressed in this work.
Figure 35: MARCM system (Scheme adopted from [25])
(A) Gal4-Gal80 system. In absence of Gal80 Gal4 binds to UAS (upstream activating sequence) and induces
expression of GFP
(B) Scheme describing the MARCM recombination from mother to daughter cell. After DNA duplication in
G2, recombination between FRT sites (grey triangle) can occur when Flippase is expressed. FRT sites are
located on the same chromatids as either Gal80 with a wildtype allele or the mutant allele of interest. Upon
recombination sister cromatids are formed that carry the wild-type allele and GAL80 and the mutant allele.
After mitosis only daughter cells that received both mutant alleles will be marked with GFP, other daughter
cells, still carrying Gal80 alleles will continue to repress GFP.
Knockdown of Lamin Dm0 does not reduce native stem cell proliferation
Comparison of control clones (just the FRT2L recombination site on a wildtype chromatid)
(Figure 36 A, B) with Dm0 null clones (FRT2L recombination site and Dm0 null allele on the
same chromatid) (Figure 36 C, D), that were induced one month prior dissection, confirmed
successful knockout of Dm0. However comparison of clonal areas did not show a significant
reduction or increase in Dm0 null clones vs control clones. This indicates that either small
hardly detectable traces of Dm0 remain that still maintain their function or that absence of
Dm0 has no effect on ISC proliferation.
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Figure 36: Lamin Dm0 null-clones show no change in uninduced stem cell proliferation
A: (UAS-CD8-GFP/+; tub-Gal80, FRT2L/ FRT2L; tub-gal4/+) Control showing no difference in Dm0 staining
comparing clonal and non clonal areas. Red border marks magnified sector B: 4 fold magnification of selected
area of (A) C: (UAS-CD8-GFP/+; tub-Gal80, FRT2L/LamD395, FRT2L; tub-gal4/+) Lamin null clone show-
ing no detectable Dm0 staining in clones and normal Dm0 staining in non clonal areas. D: 4 fold magnification
of selected area of (C) Flies were sacrificed 1 month after clonal induction. Scale bar: 25µm
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Figure 37: Induced stem cell proliferation in Lamin Dm0 null clones
A: (UAS-CD8-GFP/+; tub-Gal80, FRT2L/ FRT2L; tub-gal4/+) Control without P.e. B: Control with P.e.
shows no obvious increase in clonal vs non clonal size. C: (UAS-CD8-GFP/+; tub-Gal80, FRT2L/LamD395,
FRT2L; tub-gal4/+) Dm0 null colones do not show an obvious decrease compared to non clonal tissue. Red
outline marks GFP + clones. Scale bar: 25µm
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Dm0 null clones during induced stem cell proliferation
Since native ISC proliferation was not reduced by Dm0 knockdown, ISCs were challenged
additionally by feeding the flies Pseudomonas entomophila (P.e.). This bacterium is a part
of the Drosophila gut microbiome and induces high amounts of proliferation by activation of
the JAK/STAT pathway [43]. The effect of P.e. infection was quantified by measurement of
clonal area and by counting of phosphorylated Histone 3 (PH3) positive cells per gut inside
and outside of clones (Figure 37). PH3 marks the G2/M transition and stains condensed
chromatin just before chromosomal segregation and is therefore a short term marker of cell
proliferation. Quantification of clonal area of P.e. infected flies did show an increase of clonal
area in control-infected vs. control non-infected flies (Figure 38 A). Infected guts with Dm0 null
clones show a reduction of clonal area with a nearly significant p-value of 0.063. Quantification
of PH3 cells of infected control flies vs. non-infected control flies shows a significantly increased
amount of PH3 cells within and outside clones (Figure 38 B, 1 and 2). However no significant
decrease in PH3 cells inside clones was noted in infected guts with Dm0 null clones compared
to infected control guts (Figure 38 B, 2 and 3). A ratio of clonal versus non clonal PH3 cells
was formed to compensate for fluctuations of PH3 cells per gut, however no significant increase
in PH3 positive cells was noted comparing infected control with Dm0-null clones (p value =
0.111).
Figure 38: Quantification of Induced stem cell proliferation in Lamin Dm0 null clones
A:Quantification of clonal area of P.e. infected flies. Infected control flies do show an increase on clonal area
compared to uninfected control flies. Infected flies with Dm0 null clones show a, hardly significant, decrease in
clonal area compared to infected control flies. B: Quantification of PH3 cells in and outside of clones. Last row
for each sample shows the ratio of non clonal/clonal PH3 cells. Infected control cells show a significant increase
of PH3 cells in and outside of clones, compared to uninfected control flies. Dm0 null clonal flies do not show a
significant enough increase of non clonal/clonal PH3 ratio compared to infected control flies.
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Figure 39: String and Tribbles levels are normal in Dm0 null clones
A and C: (UAS-CD8-GFP/+; tub-Gal80, FRT2L/ FRT2L; tub-gal4/+) Control showing no difference
in String/Tribbles staining in and outside clonal areas. B and D: (UAS-CD8-GFP/+; tub-Gal80,
FRT2L/LamD395, FRT2L; tub-gal4/+) Lamin Dm0 null clones did not show altered levels of String/Trib-
bles. Some clonal cells did show remaining Dm0 staining others did show nucleoplasmic Dm0. Scale bar:
25µm
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Figure 40: Lamin C and HP1 levels are normal in Dm0 null clones
A and C: (UAS-CD8-GFP/+; tub-Gal80, FRT2L/ FRT2L; tub-gal4/+) Control showing no difference in Lamin
C/HP1 staining in and outside clonal areas. B/D: (UAS-CD8-GFP/+; tub-Gal80, FRT2L/LamD395, FRT2L;
tub-gal4/+) Lamin Dm0 null clones did not show altered levels of Lamin C/HP1. Red outline marks GFP +
clones. Scale bar: 25µm
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LaminD395 clones show no aberrant levels of cell cycle markers Tribbles and
String
Antibody staining for cell cycle markers String and Tribbles was used to test whether knockout
of Dm0 affects the cell cycle. Though Dm0 was successfully knocked out in clonal cells, no
change in String and Tribbles staining, in Dm0 null vs control clones, was recorded (Figure 39
A versus B and C versus D). Some cells in Dm0 null clones did show remaining nucleoplasmic
Dm0 staining (Figure 39 B, D). This could be due to cross reactivity with the String/Tribbles
antibody or, in some cases a non clonal cell overlayed by the GFP signal of clonal cells. In all,
the results indicate no change in cell cycle regulation in clonal vs non clonal-cells.
LaminD395 clones show no change in Lamin C and HP1 levels
Dm0 null clones were stained with Lamin C to test for altered levels possibly compensating for
Dm0 loss due to redundant functions. No considerable changes in Lamin C levels were noted
in clones vs non-clonal area or control clones (Figure 40 A, B). HP1 staining was used to test
whether the nuclear architecture or general levels of heterochromatin were changed. Also in
this case no changes in HP1 levels or its positioning in the nucleus were noticeable in clones vs
non-clones or control clones (Figure 40 C, D).
3.4 Electron microscopy (EM) analysis of Lamina
proteins
Expression of Dm0 in ISCs/EBs is associated with nuclear morphological changes that were
beforehand only recorded by immunostaining (Figure 41 A, B). Other types of nuclear changes
were recorded for Kugelkern (Figure 43 A, B) and Lamin C CaaX (Figure 42 A, B), the Lamin
C mutant allele that contains a farnesylation motif (CaaX). To gain a deeper insight into the
nature of the morphological changes associated with these proteins, a collaboration with Prof.
Georg Krohne was initiated for the use of high resolution EM imaging. Dm0, Kuk and Lamin
C CaaX were expressed in ISCs/EBs by Esg; TS and in ECs by Myo; TS.
3.4.1 Overexpression of Lamin Dm0, Kugelkern and Lamin C
CaaX lead to diverse nuclear alterations
Expression of Dm0 induced abnormal nuclear lobulations and increased immunofluorescence in
GFP-positive ISCs/EBs and ECs (Figure 41 A, B). However, also non GFP-positive ECs show
nuclear deformations. Possibly GFP-mRNA transport, GFP expression or GFP degradation,
in ECs, is affected by Dm0 expression.
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Figure 41: Effect of Lamin Dm0 on nuclear morphology
A: Overlay of GFP, DAPI and Dm0 immunostaining in ISCs/EBs and ECs. All GFP positive cells show nuclear
abnormalities, in the EC expressed Dm0 sample also non GFP cells show nuclear abnormalities. Red box marks
magnified area. B Magnification of Dm0 staining from (A). Both ISCs/EBs and ECs show nuclear lobulations
C: EM recording of ISCs/EBs and ECs. All cell types show a multilayered nuclear envelope with lobulations
and infoldings which contain either nucleoplasm or cytoplasm. NP: nucleoplasm, NE: nuclear envelope, CP:
cytoplasm, PM: plasma membrane. Blue overlay marks non nuclear regions. ISC/EB: (Esg/+; TS/UASt-Lamin
Dm0), EC: (Myo/+; TS/UASt-Lamin Dm0). 5 days of induction.
In EM recordings, ISCs/EBs as well as ECs show a multilayered nuclear envelope with
lobulations and pockets of ribosome-containing cytoplasm or nucleoplasm (Figure 41 C). Con-
sidering that a multilayered envelope naturally contains more Dm0-specific antibody binding
sites, the increased Dm0 immunostaining of GFP positive ISCs/EBs (Figure 41 A, B, ISC/EB)
is likely due to this cause.
Expression of Lamin C CaaX lead to increased immunostaining in GFP-positive ISCs/EBs
and ECs. Additionally, cytoplasmic aggregations were visible in all GFP-positive cells, in
particular ECs (Figure 42 A, B). EM imaging shows a thickened nuclear lamina in all Lamin
C expressing cells; cytoplasmic aggregations however are not visible in EM images (Figure
42 C). Possibly Lamin C CaaX forms very thin aggregates or co-localizes with other cellular
compartments and thereby remains undetectable in EM imaging.
Expression of Kuk lead to a strong immunostaining throughout the nucleus in all GFP
positive cells (Figure 43 A, B). EM recordings show vesicular structures or invaginations of
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two types inside the nucleus: vesicles with a double membrane, filled with ribosome-containing
cytoplasm, and vesicles with a single membrane filled with mostly clear fluid (Figure 43 C).
The here mentioned results are of particular interest because the show unique cellular effects
dependent on the type of lamina protein that is overexpressed. This indicates a different set of
functions for different lamina proteins, rather than mere redundancy.
Figure 42: Effect of Lamin C CaaX on nuclear morphology
A: Overlay of GFP, DAPI and Dm0 immunostaining in ISCs/EBs and ECs. Red box marks magnified area. B
Magnification of Lamin C staining from (A). ISCs/EBs show strond nuclear staining and nuclear deformations
compared to GFP negative cells. ECs show strong nuclear staining and spheric cytoplasmic aggregates. C: EM
recording of ISCs/EBs and ECs. All cell types show a thickened nuclear lamina. Cytoplasmic aggregates in
ECs were not visible. NP: nucleoplasm, NE: nuclear envelope, CP: cytoplasm, PM: plasma membrane. Blue
overlay marks non nuclear regions. ISC/EB: (Esg/UASt-Lamin C CaaX; TS/+), EC: (Myo/UASt-Lamin C
CaaX; TS/+). 5 days of induction.
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Figure 43: Effect of Kugelkern on nuclear morphology
A: Overlay of GFP, DAPI and Dm0 immunostaining in ISCs/EBs and ECs. Red box marks magnified area. B
Magnification of Kugelkern staining from (A). ISCs/EBs and ECs show increased Kuk staining throughout the
nucleus. C: EM recording of ISCs/EBs and ECs. All cell types show vesicular structures/infoldings either with
a double membrane and cytoplasmic contents or a singular membrane with clear fluid. NP: nucleoplasm, NE:
nuclear envelope, CP: cytoplasm, PM: plasma membrane. Blue overlay marks non nuclear regions. ISC/EB:
(Esg/UASt-Kuk; TS/+), EC: (Myo/UASt-Kuk; TS/+). 5 days of induction.
3.4.2 Lipin RNAi does not ameliorate the effects of Lamin Dm0
overexpression
Lipin is known to play a key role in the synthesis of phospholipids, which are an essential
part of the nuclear membrane. Also, in C. elegans, Lipin knockdown causes nuclear envelope
defects [36]. So it was assumed that knockdown of Lipin could lead to an amelioration of the
multi-nuclear envelope effect known from EM recordings of Dm0 overexpressing cells. Therefore,
a Lipin-specific antibody was generated and tested in Lipin RNAi clones (Figure 44 B). Lipin
was successfully downregulated in Lipin RNAi clones, compared to non-clonal cells, or wildtype
cells (Figure 44 A). In these clones no particular effect on Dm0 levels or distribution was
conceivable. Induction of Lipin RNAi in Dm0 expressing cells neither ameliorated the inhibitory
effect of Dm0 on proliferation, nor lead to changes in nuclear morphology. EM pictures were
also acquired from Lipin RNAi expressing ECs but no changes were notable (data not shown).
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Figure 44: Knockdown of Lipin does not alter Dm0 induced reduction of proliferation
A: (EsgTS/(Sp/CyO); FO/(Dr/TM3)) Control showing uniform lipin staining in the cytoplasm. B: (Es-
gTS/UAS-Lipin-RNAi; FO/+) Expression of Lipin RNAi successfully downregulated Lipin in clones but did
not cause visible changes to Dm0 staining. C: (EsgTS/UAS-Lipin-RNAi; FO/UASt-Dm0) Coexpression of
Lipin RNAi with Dm0 did not alter the inhibiting effect of Dm0 on ISC proliferation. No changes in nuclear
morphology are visible. Red lining marks clones. 3x enlarged detail of gut-cells in the top right of Dm0 channel
pictures. Scale bar: 25µm
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3.5 Kugelkern
Since Dm0 expression caused a strong inhibitory effect on ISCs in flipout clones, other proteins
were also tested in this system. Among them were Kugelkern (Kuk), Lamin C CaaX and
Progerin, the altered form of the human Lamin A, causing HGPS. Apart from Kuk no other
protein did caused an inhibitory effect on ISC proliferation similar to Dm0. Therefore, Kuk
was also tested for inhibition of native and JAK/STAT-induced proliferation, apoptosis and
altered nuclear transport.
Overexpression of Kugelkern inhibits native stem cell proliferation
Similar to overexpression of Dm0 in unchallenged ISCs/EBs, overexpression of Kuk in flipout
clones lead to a strong reduction in clonal area (Figure 45 B) compared to control flies (Figure
45 A). Indicating either a strong inhibitory effect on the proliferation of intestinal stem cells
or induced apoptosis. Quantification of mean fluorescence intensity of guts, overexpressing
Kuk in flipout clones, shows a highly significant reduction of clonal area in guts overexpressing
Kuk (Figure 45 C). The quantification further shows that the reduction of clonal area, upon
Kuk overexpression, has very little variability compared to control flies. This effect is also
reminiscent of Dm0 overexpression in flipout clones. The overexpression of Kuk was confirmed
by the localization of Kuk throughout the nucleus, previously known from overexpression of
Kuk in Esg; TS and Myo; TS lines (Figure 43 A, B).
Kugelkern overexpression does not induce apoptosis
Compared to wildtype (Figure 46 A) Caspase staining neither changed in intensity nor local-
ization, in Kuk expressing clones (Figure 46 B). In both cases clonal cells with (Figure 46 2)
and without (Figure 46 1) Caspase staining were recorded. The positive control in wing discs
(Figure 14 C, D) indicates that those Caspase positive cells show low level background staining
of the Caspase antibody and not Caspase levels equal to actual activation of apoptosis.
Additionally it was attempted to ameliorate the effects of Kuk by coexpressing Kuk and the
”Drosophila inhibitor of apoptosis” (DIAP) protein (Figure 47). Coexpression of DIAP how-
ever did not change the proliferative behavior of Kuk overexpressing ISCs. In all, the results
indicate that Kuk overexpression in ISCs does not induce apoptosis and that the reduction of
clonal area, in Kuk overexpressing flipout clones, is likely due to inhibition of ISC proliferation.
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Figure 45: Kugelkern overexpression inhibits native stem cell proliferation
A: (EsgTS/(Sp/CyO); FO/(Dr/TM3)) Control. B: (EsgTS/UASt-Kuk; FO/+) Kuk overexpression leads to a
strong reduction of stem cell proliferation. C: Quantification of stem cell proliferation by mean fluorescence/gut,
normalized to control. Clonal induction for 5 days. Scale bar: 25 µm
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Figure 46: Kugelkern overexpression does not affect Caspase levels
A: (EsgTS/(Sp/CyO); FO/(Dr/TM3)) Control showing relatively uniform Caspase staining of cells in the optical
plane. B: (EsgTS/UASt-Kuk; FO/+) Expression does not change levels of Caspase staining. (1) Clonal cells
without Caspase staining. (2) Clonal cells with Caspase staining. Clonal induction for 5 days. Red outline
marks GFP + clones. Scale bar: 25µm
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Figure 47: Expression of DIAP does not reduce Kugelkern induced reduction of stem cell
proliferation
A: (EsgTS/(Sp/CyO); FO/(Dr/TM3)) Control. B: (EsgTS/UASt-Kuk; FO/+) Kuk expression reduces ISC
proliferation compared to control. C: (EsgTS/UASt-Kuk; FO/UAS-DIAP) Coexpression of DIAP does not
change proliferation behavior of Kuk expressing ISCs. Clonal induction for 5 days. Scale bar: 25µm
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Figure 48: Kugelkern overexpression inhibits UPD induced stem cell proliferation
A: (EsgTS/(Sp/CyO); FO/(Dr/TM3)) Control. B: (EsgTS/UAS-UPD; FO/+) Expression of UPD induces
strong ISC proliferation with clones covering most of the intestinal surface. C: (EsgTS/UAS-UPD; FO/UASt-
Kuk) Coexpression of Kuk with UPD significantly reduces proliferation even below wildtype levels. D: Quan-
tification of mean fluorescence of phenotypes A, B, C. Clonal induction for 5 days. White box in Dm0 and Kuk
staining marks 3 x enlarged exemplary cells. Scale bar: 25µm
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Kugelkern inhibits UPD induced stem cell proliferation
To test whether Kuk expression could inhibit JAK/STAT-induced ISC proliferation similar to
Dm0, Kuk was coexpressed with UPD in flipout-clones and compared to wildtype and cells
expressing only UPD (Figure 48 A, B, C). Immunostaining in UPD expressing guts revealed a
higher occurrence of small cell types with higher Kuk and Dm0 staining (Figure 48 B), indicating
increased prolifaration of ISCs. Also a significant increase in clonal area was recorded in these
guts (Figure 48 D). In cells with UPD and Kuk overexpression Dm0 and Kuk staining was
distributed throughout the nucleus in a similar manner (Figure 48 C, small box). Dm0 shows
costaining with Kuk throughout the nucleus. This was recorded before and is typical for Kuk
overexpression. Kuk overexpression significantly reduced JAK/STAT-induced proliferation to
levels even significantly lower than wildtype (Figure 48 D).
3.5.1 Effect of Kugelkern on nuclear transport
To test whether the inhibitory effect of Kuk is due to impairment of nuclear transport, a set of
different sized GFP constructs was used to probe for altered transport behavior of Kc167 cells.
The fusion-constructs are 1x, 2x, 5x, and 10x repetitions of GFP plus a DAM methylase and
a nuclear localization sequence (NLS). After transfection, the cells showed different limitations
of the constructs to enter the nucleus (Figure 49). All cells transfected with the 1x GFP and
2x GFP constructs showed a binary logarithm (log2) of the nucleoplasmic/cytoplasmic (np/cp)
ratio bigger/equal to 1, indicating no hindrance of the constructs to enter the nucleus. However,
cells transfected with the 5x GFP and 10x GFP construct showed increasing numbers of cells
with smaller NP/CP ratios (Figure 50 A), indicating increased numbers of cells where the
fusion constructs were unable to enter the nucleus. For instance about 27% of cells transfected
with the 5x GFP construct showed a log2 NP/CP smaller/equal 1 (and bigger/equal to 0)
and about 14% with a log2 (NP/CP) bigger/equal to -1 (and smaller/equal to 0). This trend
intensifies in 10x GFP transfected cells where the majority of cells has a stronger cytoplasmic
than nucleoplasmic staining, indicating that in most cells the majority of 10x fusion constructs
were unable to enter the nucleus. Upon coexpression of Kuk, the general distribution of cells
with nucleoplasmic ratios typical to their constructs does not change significantly (Figure 50
B). According to this result, Kuk overexpression does not influence the nuclear transport.
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Figure 49: 1x, 2x, 5x, 10x GFP constructs.
Exemplary selection of cells transfected with 1x, 2x, 5x, 10x-GFP constructs shows typical nucleoplasmic/cy-
toplasmic distribution for each transfected construct. Nuclei are identified by DAPI and increased (1xGFP,
2x-GFP) or decreased (5xGFP, 10x-GFP) GFP signal. GFP constructs are able to enter the nucleus at sizes
1xGFP to 2xGFP but are increasingly excluded from the nucleus at sizes 5xGFP to 10xGFP. Scale bar 5 µm.
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Figure 50: Overexpression of Kugelkern does not alter nuclear transport. Quantification
Bar diagram of % of cells transfected with 1x, 2x, 5x, 10x GFP constructs, without Kuk (A) and with Kuk (B),
with binary logarithms of measured nucleoplasmic/cytoplasmic ratios ranging from bigger/equal 1 (more GFP
measured in the nucleus) to smaller/equal -1 (more GFP measured in the cytoplasm). Both A and B show
an increase of cells that have more GFP in the cytoplasm when higher number GFP constructs (5x, 10x) are
expressed.
3.5.2 Treatment with the farnesyl transferase inhibitor ABT100
To reproduce previous results that were generated by Dr. Annely Brandt and were indicating
that treatment of cells with the farnesyl transferase inhibitor ABT100 could reduce nuclear
shape changes induced by Kuk expression (unpublished data-Dr Annely Brandt). Kc167 cells
were treated with different concentrations of ABT100. The cells however did not respond to
previously reported doses (6 µm of ABT100) so several higher doses were tested (12,4 µM,
60 µM, 120 µM, Figure 51 B, C, D). However, even at double the dose of ABT100, cells did
not show nucleoplasmic Kuk or Dm0 staining (Figure 51 A, 1, B, 1). Some cells did show
increased nucleoplasmic staining of Kuk and Dm0 in comparison to their peers but this effect
was also visible in the control cells (Figure 51 2), which was probably due to cells lying in a
different optical plane. Only at a 10 times higher dose of ABT did cells show increased levels of
nucleoplasmic Kuk but not Dm0 (Figure 51 C, 3). Only at a 20 times higher dose of ABT100
did cells show also an increase of nucleoplasmic Dm0 (Figure 51 C, 4).
Since Kc167 cells showed an effect of ABT100, though at much higher doses than reported,
similar doses were tested in flies. However neither in gut nor in muscle tissue did these doses had
any effect. In a last attempt, a 161 times higher dose was administered to GFP-Kuk expressing
cells (Figure 52 B, D) but did not result in significant changes of Kuk or GFP-Kuk in muscle or
intestinal cells. It can be argued that the strongest effect should be visible in GFP-Kuk levels
since GFP-Kuk is freshly synthesized together with ABT100 treatment, due to transfection,
but Kuk and GFP-Kuk distribution at the nuclear envelope and the nucleoplasm was similar.
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It can be concluded that though ABT100 did show an effect on Kc167 cells, it was at much
higher doses and therefore ABT probably lost most of its activity. Since this ABT100 sample
was a one time gift of Abbot to the Großhans lab and production of ABT100 never initiated,
no new ABT100 could be acquired. It is unclear however why high doses of ABT100, that were
significantly inhibiting farnesylation in Kc167 cells, were not able to inhibit farnesylation in
gut and muscle tissues. Presumably only a small portion of ingested ABT100 can be taken up
by the intestine. Considering the potential reduction of ABT100 activity, the portion of active
ABT100 taken up by the intestine route would be negligible for any cellular effect in muscles.
Also gut cells were stained for Dm0 and Kuk upon ingestion of high ABT100 doses (data not
shown) and no significant effect was observable.
Figure 51: ABT100 treatment in Kc167 cells
Treatment of Kc167 cells with ABT100 for 3 days. A: control, B: ABT concentration in supernatant 12,4 µM
C: 60 µM, D: 120 µM. (1) Cells which show no change in nucleoplasmic Kuk or Dm0 levels. (2) Cells which
appear to be having increased levels of nucleoplasmic Kuk/Dm0 but are also found in control and are probably
in a different optical plane. (3) Cells which show increased levels of nucleoplasmic Kuk but not Dm0. (4) cells
which show increased nucleoplasmic Kuk and Dm0. WGA: Wheat germ aglutinin, Scale bar: 5µm
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Figure 52: ABT100 treatment in muscle and midgut
A: Control. Muscle cells expressing Kuk without ABT100. B: Muscle cells expressing Kuk with 1 mM ABT100
concentration in food. C: Control. Intestinal cells expressing Kuk without ABT100. Sideview of gut epithelium
with lumen on the right. D: Intestinal cells expressing Kuk with 1 mM ABT100 concentration in food. Sideview





4.1.1 Overexpression of Dm0 inhibits ISC proliferation by
inhibition of the JAK/STAT pathway
Initial experiments have shown that Dm0 overexpression induces a significant reduction in ISC
proliferation in native conditions (Figure 12). This could possibly result from ablation of either
ISCs or EBs. However, no significant decline of GFP-positive ISCs/EBs was noted that could
explain such a strong effect. Also, midguts of flies with Dm0 overexpression were stained with
Caspase-3 antibody that was successfully tested in fly wing discs (Figure 14 C and D) and by
the supplier (Figure 14 E). Though the antibody stained both the active form of Caspase-3
and the inactive procaspase form, it showed a much higher specificity to the active form. Con-
sidering this and the fact that Caspase-3 staining of wildtype cells was similar to Caspase-3
staining in Dm0 overexpressing cells (Figure 14 A and B), it can be concluded that levels of
active Caspase 3 were not increased in Dm0 overexpressing cells. Additionally, the effect of
Dm0 overexpression could be overruled by the coexpression of Notch RNAi in ISCs (Figure 15
C1 and C2). This lead to the formation of Notch-tumors which were smaller than Notch-tumors
induced in wildtype flies but similar in occurrence throughout the midgut. This shows that
Dm0 overexpressing ISCs did not lose their ability to proliferate.
Since Dm0 overexpression did not harm or alter basic ISC identity, it was reasonable to test
whether it affects the signaling pathways responsible for ISC proliferation. However only acti-
vation of JAK/STAT and Hippo signaling pathways resulted in a clear increase in ISCs prolif-
eration (Figure 17, Figure 19 A and B, Figure 18 A and B). Coexpression of Dm0 with UPD or
Warts RNAi resulted in a drastic reduction of ISC proliferation in both cases (Figure 19 C, Fig-
ure 18 C) but since Hippo-induced Stem cell proliferation requires a basic level of JAK/STAT
signaling, both phenotypes could result from an inhibition of the JAK/STAT pathway.
The comparative analysis of Dm0 and Stat levels in UPD and Dm0 overexpressing midguts
revealed that Dm0 and Stat levels are anticorrelated (Figure 23). This further strengthens the
hypothesis that Dm0 affects the JAK/STAT pathway. However, no general decrease in Stat
levels was recorded in ISCs/EBs during Dm0 expression alone. Instead, some GFP-positive
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cells have higher Stat levels while others don’t show Stat staining (Figure 22 D, 1 and 2). It
is possible that Stat levels are different in ISCs, EBs and EEs. Since all three cell types are
marked by GFP in the flipout system, no distinction is possible. Additional experiments might
help to answer that question.
Expression of Stat∆N∆C was used to initiate the JAK/STAT pathway activation at the level
of Stat to test whether Dm0 would act upstream or downstream of Stat. No significant increase
in proliferation was noted upon Stat∆N∆C expression however Stat staining was drastically
reduced in clonal cells in contrast to increased Stat staining in non clonal cells. This indi-
cates that Stat∆N∆C was expressed effectively and that Stat levels would decrease due to
SOCS36E-mediated feedback. Stat∆N∆C is possibly also inducing upregulation if JAK/STAT
signaling in neighboring non clonal cells. This would likely increase their proliferation and
thereby put them in direct competition to clonal cells, which would explain why clonal area
did not increase upon Stat∆N∆C expression. If this scenario is true, Dm0 overexpression did
successfully downregulate Stat∆N∆C-induced proliferation, thereby indicating a point of effect
downstream of Stat.
dMyc was reported to function downstream of JAK/STAT, Hippo and EGFR signaling and
regulate their effects on ISC proliferation (Figure 27 A) [74]. Therefore it was conceivable
to test whether Dm0 overexpression would alter dMyc levels. However no significant changes
were noted. It is possible that dMyc requires a higher level of upstream pathway activation
first, to increase levels significantly enough to be affected by Dm0. It could also mean that
Dm0 overexpression in a situation of low JAK/STAT, Hippo and EGFR pathway activity in-
hibits proliferation differently than in a situation of cellular stress with high pathway activity.
Both hypotheses fit with the observation that small GFP-positive cell types show a mixed Stat
staining with Dm0 overexpresson alone whereas in a situation with Dm0 and UPD coexpres-
sion levels of Stat in clonal cells are lower throughout. At this stage, at any rate, no conclusive
estimation about the role of dMyc in Dm0 mediated inhibition of proliferation can be given.
RNAseq analysis has revealed a possible modus operandi for Dm0 mediated inhibition of ISCs.
Transcripts for the UPD receptor domeless (dome) are significantly increased in samples with
JAK/STAT pathway activation (Table 7 dome). However upon coexpression of Dm0 and UPD
domeless transcripts are reduced to normal levels. This indicates that Dm0 affects JAK/STAT
signaling on a transcriptional level, by downregulating the UPD receptor domeless. Secreted
UPD from enterocytes can not effectively activate the JAK/STAT pathway and thereby initiate
the proliferative response of ISCs.
Interestingly domeless transcript levels are not downregulated upon Dm0 expression alone.
This indicates that in a regular situation with low JAK/STAT activity Dm0 likely represses
ISC proliferation in a different manner.
It can be concluded that Dm0 likely suppresses the activated JAK/STAT pathway on a tran-
scriptional level by downregulating the UPD receptor domeless.
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Figure 53: Model for Dm0 mediated inhibition of ISC proliferation
Upon overexpression, Dm0 downregulates domeless transcripts which leads to the inhibition of the JAK/STAT
pathway and thereby, decrease in ISC proliferation. Hippo pathway induced proliferation is dependent on a
basal level of JAK/STAT activity, the pathway is possibly inhibited indirectly by downregulation of Jak/Stat or
more directly, by Dm0 affecting transcription and upregulating pathway components (Red arrows). (*) markes
Hippo pathway components (Jub, Brm) that induce proliferation. Fat, Mer, Sav were upregulated and reduce
proliferation. Dm0 induced inhibition of ISC proliferation can be overruled by Delta/Notch signaling which
activates the EGFR pathway in ISCs, thereby inducing proliferation.
Jack/Stat pathway components: Unpaired (UPD), Domeless (Dome), Hopscotch (Hop), Stat. Hippo pathway
components: Dachsous, Fat, Merlin (Mer), Hippo (Hpo), Yorkie (Yki), Salvador (Sav), Warts (Wts), Ajuba
(Jub), Brahma (Brm), Scalloped (Sd).
The Hippo pathway is possibly repressed by Dm0 indirectly since it requires a certain level
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of JAK/STAT activity to induce proliferation (Picture 53). However Dm0 is likely also affecting
the Hippo pathway directly. 5 genes that are part of Hippo signal transduction were identified
by GO analysis that were upregulated upon Dm0 overexpression. Two of them would result in
increased proliferation, Ajuba a negative regulator of Warts [73] and Brahma(Brm) which binds
Yorkie (Yki) and is required for Yki activation [94]. The three other genes are tumor suppressors
that play key roles upstream of Warts. Salvador (Sav) which forms a repressive complex with
Hpo and Warts [69, 88], Merlin (Mer) which recruits Wts for consecutive phosphorylation and
activation [91] and fat which is is a cell-surface receptor that binds to Dachsous and thereby
promotes Hippo signaling[57]. Though the five upregulated genes represent a mixed situation
for increase ore decrease of ISC proliferation, the balance is on the side of inhibition. 3 of
the five genes decrease proliferation and the strongest increase in transcript numbers is noted
with the receptor fat (Table 36). Also in its function as receptor the strongest regulatory
function can be considered here. Therefore it can be concluded that Dm0 overexpression leads
to a reduction of proliferation by affecting the Jak/Stat and Hippo pathway. Whether the
effects on Hippo are due to the downregulation of Jak/Stat or more directly remains unclear.
Delta/Notch signaling however can partially overrule the inhibitory effect of Dm0, possibly by
activation of EGFR signaling [71].
4.1.2 Cell cycle control
The authors that introduced the flyFUCCI system tested it in ISCs, under the control of the
Delta promoter, and in EEs, under the control of the prospero promoter, in wildtype flies [95].
They reported that about 40% of ISCs were in G2, about 57% in G1 and about 3% in S-phase.
EEs were about 90% in G2, 7% in G1 and 3% in S-phase. EBs were not tested. Upon stress
induction by feeding of Pseudomonas entomophila, the number of ISCs in G2 increased from
about 57% to 70% and the number of ISCs in S phase from 3% to 8%.
The fact that most of the ISCs/EBs that were tested in this work were found in G2-phase
(Figure 29) indicates that EBs are likely, similar to EEs, mostly in G2 phase and that the cells
in G1 are mostly ISCs. Overexpression of Dm0 in ISCs/EBs lead to an increase in the number
of cells in G2 and S-phase. Considering that ISCs reportedly shifted into G2 and S-phase upon
stress induction, this might indicate a type of stress response in ISCs upon Dm0 overexpression.
However the increase in S phase reported in the paper[95] is possibly a byproduct of increased
division.
To summarize, Dm0 affects the cell cycle in ISCs/EBs though it is not clear which of the two
cell types are affected in which way. Thereby it is uncertain how to interpret the finding at
this point. If ISCs are the cells that shift from G1 to G2 and S-phase, this indicates a similar
response to Dm0 overexpression as to P.e. ingestion. However since Dm0 has an inhibitory
effect on proliferation the increase in S-phase is unlikely a result of proliferation. However cells
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could be arrested or slowed in S-phase.
4.1.3 Gene expression of Dm0 overexpressing ISCs/EBs
Since overexpression of Dm0 together with UPD lead to the normalization of about 50% of
the UPD-induced transcripts, the effect of Dm0 on UPD is likely specific (Figure 31). The
normalization of domeless transcripts in UPD and Dm0 coexpressing samples gives also a lo-
cus for this interaction. Therefore many target genes of JAK/STAT signaling might simply
be affected downstream. On the other hand, GO analysis of Dm0 and UPD overexpressing
samples revealed that also Dm0 specific transcripts were affected by UPD expression (Figure
32 C). These transcripts mostly lie in the transport category, a category that was also present
in samples with UPD expression alone. It seems that Dm0 and UPD affect each other in this
particular field leading to the complete absence of transport specific transcripts with significant
up or downregulation. No effect on transport behavior was found in cell culture experiments
with transfected Dm0 (Figure 30 C) so at least nuclear/cytoplasmic transport appears to be
unaffected. What other types of transport might be altered by Dm0 and possibly normalized
by UPD or vice versa, is uncertain. Additionally UPD and Dm0 overexpressing samples show
the appearance of transcripts categorized into the group ”G-protein coupled receptor signaling
pathway ” ,a new category that was not present before in either only UPD or Dm0 overex-
pressing samples. As G-protein signaling is involved in many different processes no particular
interpretation can be made at this point [41].
Several pathway candidates were specifically searched for in the pool of significantly up or down-
regulated transcripts. The tested categories involved apoptosis, cell cycle and the ISC prolifera-
tion regulating signaling pathways EGFR, JAK/STAT, Hippo, Wg/Wn and BMP/Dpp. UPD2
is downregulated upon UPD1 overexpression likely due to the effect of the SOCS36E-mediated
negative feedback loop that is however overruled by constant UPD1 transcript expression.
Interestingly Notch transcripts are upregulated in all three samples however possibly due to
different reasons. In case of UPD the increased overproliferation of ISCs probably leads to an
increased number of EBs which have higher levels of Notch expression. On the other hand the
fact that Notch transcripts are upregulated upon Dm0 overexpression might indicate a similar
effect on stem cells as was reported by Scaffidi and Misteli 2008 [78]. The authors reported an
upregulation of Notch target genes in HGPS-patient mesenchymal stem cells.
Comparison of LADs with significantly up or downregulated transcripts showed no correlation
with either induction or repression of genes in samples with Dm0 overexpression. It is possible
that Dm0 plays no role in the organization of LADs as this result falls into line with a recently
published paper, stating that lamins play no role in organization of LADs in mouse [4].
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4.1.4 Lamin function
Quantification of clonal area of P.e. infected flies did show an increase of clonal area in control-
infected vs. control non-infected flies (Figure 38 A). Infected guts with Dm0 null clones show a
reduction of clonal area with a p-value of 0.063 which is close to the generally accepted statisti-
cal significance level of 0.05. This alone could indicate a repressive effect on the ability of clonal
cells to proliferate. However the increase of clonal area in infected control cells vs. non-infected
control cells rather indicates a general variability of the system as there is no reason why clonal
cells in the infected control sample should proliferate more than non-clonal cells. This rea-
soning clearly reduces the chance of a significant effect of Dm0 knockdown on the ability of
ISCs to proliferate. Quantification of PH3 cells of infected control flies vs. non-infected control
flies shows a significantly increased amount of PH3 cells within and outside clones (Figure 38
B). This indicates that the P.e. infection was successfully inducing ISC proliferation. Infected
flies with Dm0 knockdown clones showed an even stronger increase of PH3-positive cells in
non-clonal areas but a decreased amount of PH3-positive cells in Dm0 null clones, compared
to infected control cells. The effect however, was not significant enough to justify the proposal
of an inhibitory effect. It could be argued that since P.e. infectiousness varies from fly to fly
the best indicator for an inhibitory effect of Dm0 knockdown would be the ratio of clonal vs
non-clonal cells, indicating how much proliferation would be inhibited in clones vs non-clonal
cells. An increase in this ratio would indicate a stronger discrepancy in clonal vs non-clonal
proliferation. Flies with clonal Dm0 knockdown indeed show the highest non-clonal/clonal ra-
tio in PH3-positive cells. However the effect was still not significant due to strong variation of
PH3 cells per gut in all infected flies. Therefore a preliminary conclusion is that an inhibitory
effect of Dm0 knockdown on stem cells is possible; however more data has to be generated to
increase the significance of the effect. Furthermore, it is unclear whether a complete knockdown
was achieved since an ISC, with the recombination event, starts with a normal amount of Dm0
that is consecutively thinned out with each division. A remaining rest however might still hold
essential functionality.
4.2 EM analysis of Lamina proteins
EM recordings of Dm0 overexpressing ISCs and ECs both show a multi layered nuclear pheno-
type with enclosures of ribosome containing cytoplasm (Figure 41 C). It is conceivable that the
proliferating nuclear envelope wraps itself several times around the nucleus thereby trapping
cytoplasmic content. This scenario could explain why Dm0 overexpressing ISCs often show a
distinct GFP staining at the nuclear cortex. It is also intriguing that despite such a severe phe-
notype ISCs are still able to proliferate upon Notch RNAi expression. It can be hypothesized
that either the multi-layered nuclear envelope is not limiting for cell division or it is thinned out
4.3. KUGELKERN 103
enough by consecutive division to not reach limiting levels. It is also surprising that, consider-
ing the likely obstruction of a multi-layered nuclear envelope, no change in transport behavior
was observed in Kc167 cells (Figure 30). Dm0 overexpressing Kc167 cells show changed nuclear
morphology and increased Dm0 staining at the nuclear cortex but it is unclear if this results
from the same structural origin as in Dm0 overexpressing intestinal cells.
Immuno pictures of ISCs and ECs overexpressing Lamin C CaaX did show several cytoplasmic
aggregations in particular in ECs (Figure 42 A and B) these aggregations, that even can form
ring structures, were not visible in EM pictures (Figure 42 C). Instead they show a thickened
lamina which is also represented by increased immunostaining . It is possible however that
the sphere shaped cytoplasmic aggregates indicate a general tendency of farnesylated Lamins
to assemble into round shapes. This is plausible since one of the functions of the lamina is to
provide stability to the nucleus.
EM recordings of Kuk overexpressing ISCs and ECs both show invaginations or vesicles with
either cytoplasmic content or a clear fluid (Figure 43 C). It is conceivable that the first type
is caused by invagination of the nuclear envelope from the cytoplasm, therefore containing ri-
bosomes, and the second type by invagination of the inner nuclear membrane, therefore only
containing fluid present in the perinuclear space and ER. The density of vesicles also explains
why immuno-staining of cells that overexpress Kuk led to a staining throughout the nucleus
instead of only the nuclear cortex. Kuk is likely coating the vesicles/invaginations thereby
directing antibodies to the vesicles/invaginations. It can be hypothesized whether Kuk plays a
role in the formation of the nucleoplasmic reticulum since also the nucleoplasmic reticulum has
two known forms. One with cytoplasmic content enveloped with a double membrane and one
with inter membrane space enveloped with a single membrane. [38, 56]. Farnesylated Prelamin
A plays a role in the formation of the nucleoplasmic reticulum in mice [38] but since Drosophila
does not have a Lamin A allele it is possible that Kuk has taken over this role, possibly in
concert with condensins [11].
4.3 Kugelkern
Kuk and Dm0 have shown several functional similarities. Overexpression of both induces
ageing-like phenotypes in Drosophila, like decrease in fitness and lifespan. They also both show
cellular effects attributed to HGPS, like misshaped nuclei, decrease in heterochromatin and
increase in DNA damage [13]. However the nuclear distribution of Kuk and Dm0 is different
for the overexpression of each protein. While Dm0 overexpression induces a thick layer of Dm0
staining at the nuclear envelope, Kuk overexpression induces immunostaining of Kuk and Dm0
throughout the nucleus. Both effects can be explained by the recorded EM pictures. While
Dm0 staining is increased due to a multilayered nuclear envelope, upon Dm0 overexpression,
Kuk staining is found throughout the nucleus due to invaginations or vesicles that entered
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the nuclear space (Figure 41 C, Figure 43 C). The fact that Dm0 co-localizes with Kuk in
these cases, indicates that in both situations the two lamina proteins, and likely others, were
transported along with invaginations/vesicles or multilayered nuclear envelope. In this work
it is shown that Kuk also inhibits native ISC proliferation (Figure 45) and UPD1 induced
proliferation, though to a slightly lower degree. It is remarkable that, despite these similarities,
Dm0 and Kuk show very different cellular phenotypes upon overexpression . Also despite the
apparent severity of the nuclear phenotype, Kuk overexpression did not not change Caspase
levels compared to control (Figure 46 A and B) and expression of DIAP did not change the
inhibiting effect on ISC proliferation (Figure 47). Both findings indicate that overexpression of
Kuk does not induce apoptosis. Considering the severety of the structural changes visible in
EM pictures of Kuk overexpressing ISCs/EBs and ECs it is surprizing that Kuk overexpressing
Kc167 cells did not show any significant changes in nuclear transport behavior (Figure 50 A
and B). It is possible that Kuk acts differently on Kc167 cells than intestinal cells.
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Table 10: Control vs Dm0 overexpression: 30 candidates with strongest increase in transcript
levels compared to control
Nr Flybase gene id external gene name log2 fold change
1 FBgn0035638 Tektin-C 7.03
2 FBgn0039551 Or98a 5.29
3 FBgn0085386 CG34357 5.29
4 FBgn0034415 CG15116 4.50
5 FBgn0261804 CG42750 4.47
6 FBgn0263219 Dscam4 4.40
7 FBgn0051708 CG31708 4.18
8 FBgn0034506 CG13870 4.11
9 FBgn0035776 CG8564 3.74
10 FBgn0036654 CG9692 3.62
11 FBgn0250910 Octbeta3R 3.62
12 FBgn0034692 CG13502 3.60
13 FBgn0002525 Lamin Dm0 3.59
14 FBgn0052207 CG32207 3.52
15 FBgn0034505 CG16739 3.50
16 FBgn0263332 3.46
17 FBgn0031747 CG9021 3.45
18 FBgn0035187 Trh 3.45
19 FBgn0052364 CG32364 3.35
20 FBgn0263328 3.29
21 FBgn0262169 magu 3.18
22 FBgn0263250 CG43393 3.16
23 FBgn0052625 CG32625 3.13
24 FBgn0034408 sano 3.03
25 FBgn0264721 3.03
26 FBgn0034910 CG4763 2.92
27 FBgn0033469 CG12133 2.90
28 FBgn0259683 Ir40a 2.90
29 FBgn0085452 CG34423 2.89
30 FBgn0036997 CG5955 2.87
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Table 11: Control vs Dm0 overexpression: 30 candidates with strongest decrease in transcript
levels compared to control
Nr Flybase gene id external gene name log2 fold change
1 FBgn0040104 lectin-24A -4.02
2 FBgn0032336 Ast-C -4.01
3 FBgn0015591 Ast -3.56
4 FBgn0042110 CG18765 -3.53
5 FBgn0039470 CG6296 -3.46
6 FBgn0004430 LysS -3.26
7 FBgn0082950 snoRNA:Me18S-G1952 -3.25
8 FBgn0004428 LysE -3.21
9 FBgn0031248 CG11912 -3.13
10 FBgn0259722 CG42376 -3.11
11 FBgn0036101 NijA -3.10
12 FBgn0039316 CG11893 -3.07
13 FBgn0039114 Lsd-1 -3.04
14 FBgn0053867 His-:CR33867 -3.02
15 FBgn0082926 snoRNA:Me28S-U1848 -3.01
16 FBgn0086057 snoRNA:Me28S-G2017 -2.99
17 FBgn0038147 CCHa2 -2.95
18 FBgn0037291 CG14662 -2.90
19 FBgn0053346 CG33346 -2.88
20 FBgn0004872 piwi -2.87
21 FBgn0036953 CG17145 -2.85
22 FBgn0264002 DmsR-2 -2.84
23 FBgn0000071 Ama -2.77
24 FBgn0013276 Hsp70Ab -2.77
25 FBgn0053337 CG33337 -2.76
26 FBgn0036713 Mip -2.74
27 FBgn0085415 CG34386 -2.68
28 FBgn0036440 CG17177 -2.62
29 FBgn0086677 jeb -2.59
30 FBgn0013678 mt:Cyt-b -2.59
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Table 12: Control vs UPD overexpression: 30 candidates with strongest increase in transcript
levels compared to control
Nr Flybase gene id external gene name log2 fold change
1 FBgn0004956 UPD1 4.84
2 FBgn0053508 ppk13 4.46
3 FBgn0053543 CG33543 4.40
4 FBgn0031935 CG13793 3.72
5 FBgn0033574 Spn47C 3.62
6 FBgn0027578 CG14526 3.42
7 FBgn0031936 CG13794 3.38
8 FBgn0050104 NT5E-2 3.31
9 FBgn0034462 CG15905 3.12
10 FBgn0032713 CG17323 3.00
11 FBgn0034374 CG15086 2.94
12 FBgn0053509 CG33509 2.87
13 FBgn0034195 Spn53F 2.67
14 FBgn0032683 kon 2.60
15 FBgn0034196 CG15605 2.57
16 FBgn0015400 kek2 2.54
17 FBgn0031850 Tsp 2.53
18 FBgn0085753 pseudogene:CR40596 2.41
19 FBgn0034463 CG15125 2.38
20 FBgn0000527 e 2.38
21 FBgn0036951 CG7017 2.36
22 FBgn0020414 Idgf3 2.30
23 FBgn0044812 TotC 2.25
24 FBgn0033921 tej 2.23
25 FBgn0028945 CG7631 2.21
26 FBgn0051148 CG31148 2.17
27 FBgn0052198 CG32198 2.16
28 FBgn0039670 CG7567 2.15
29 FBgn0052302 CG32302 2.08
30 FBgn0052817 CG32817 2.05
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Table 13: Control vs UPD overexpression: 30 candidates with strongest decrease in transcript
levels compared to control
Nr Flybase gene id external gene name log2 fold change
1 FBgn0033774 CG12374 -6.27
2 FBgn0004428 LysE -6.10
3 FBgn0004430 LysS -6.04
4 FBgn0027109 npf -4.77
5 FBgn0036953 CG17145 -4.41
6 FBgn0039470 CG6296 -4.40
7 FBgn0004426 LysC -3.99
8 FBgn0011556 zetaTry -3.98
9 FBgn0039471 CG6295 -3.63
10 FBgn0003357 Jon99Ciii -3.58
11 FBgn0000337 cn -3.57
12 FBgn0004427 LysD -3.43
13 FBgn0003358 Jon99Ci -3.39
14 FBgn0040091 Ugt58Fa -3.38
15 FBgn0040104 lectin-24A -3.35
16 FBgn0031261 nAcRbeta-21C -3.35
17 FBgn0031220 CG4822 -3.31
18 FBgn0020907 Scp2 -3.23
19 FBgn0023197 Jon74E -3.22
20 FBgn0038878 CG3301 -3.20
21 FBgn0039472 CG17192 -3.16
22 FBgn0051041 CG31041 -3.07
23 FBgn0051774 fred -3.07
24 FBgn0051266 CG31266 -3.02
25 FBgn0052379 CG32379 -2.99
26 FBgn0263250 CG43393 -2.98
27 FBgn0033541 CG12934 -2.98
28 FBgn0031653 Jon25Biii -2.96
29 FBgn0010425 epsilonTry -2.95
30 FBgn0263746 -2.92
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Table 14: Control vs UPD & Dm0 overexpression: 30 candidates with strongest increase in
transcript levels compared to control
Nr Flybase gene id external gene name log2 fold change
1 FBgn0053508 ppk13 7.38
2 FBgn0035638 Tektin-C 6.98
3 FBgn0085386 CG34357 6.51
4 FBgn0039551 Or98a 6.21
5 FBgn0053509 CG33509 6.20
6 FBgn0031935 CG13793 6.13
7 FBgn0031936 CG13794 5.90
8 FBgn0035187 Trh 5.52
9 FBgn0250910 Octbeta3R 5.46
10 FBgn0039482 CG14258 5.42
11 FBgn0039479 CG14257 5.42
12 FBgn0038239 CG14850 5.36
13 FBgn0036654 CG9692 5.29
14 FBgn0034463 CG15125 5.23
15 FBgn0004956 UPD1 5.04
16 FBgn0263328 5.03
17 FBgn0261429 5.03
18 FBgn0053922 CG33922 4.98
19 FBgn0083945 CG34109 4.98
20 FBgn0034462 CG15905 4.97
21 FBgn0032713 CG17323 4.95
22 FBgn0034374 CG15086 4.87
23 FBgn0053543 CG33543 4.85
24 FBgn0053296 CG33296 4.82
25 FBgn0040602 CG14545 4.70
26 FBgn0052625 CG32625 4.70
27 FBgn0035777 CG8563 4.69
28 FBgn0053923 CG33923 4.69
29 FBgn0026255 clumsy 4.66
30 FBgn0035316 CG15878 4.63
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Table 15: Control vs UPD & Dm0 overexpression: 30 candidates with strongest decrease in
transcript levels compared to control
Nr Flybase gene id external gene name log2 fold change
1 FBgn0033774 CG12374 -7.13
2 FBgn0004428 LysE -5.23
3 FBgn0004430 LysS -4.81
4 FBgn0038878 CG3301 -4.66
5 FBgn0040091 Ugt58Fa -4.20
6 FBgn0036953 CG17145 -4.05
7 FBgn0023197 Jon74E -3.97
8 FBgn0051774 fred -3.97
9 FBgn0031220 CG4822 -3.89
10 FBgn0003358 Jon99Ci -3.85
11 FBgn0040104 lectin-24A -3.79
12 FBgn0039471 CG6295 -3.66
13 FBgn0003357 Jon99Ciii -3.49
14 FBgn0004426 LysC -3.45
15 FBgn0031219 CG13694 -3.45
16 FBgn0031630 CG15629 -3.39
17 FBgn0031261 nAcRbeta-21C -3.29
18 FBgn0036833 CG3819 -3.27
19 FBgn0004427 LysD -3.20
20 FBgn0011556 zetaTry -3.17
21 FBgn0030756 CG9903 -3.06
22 FBgn0050090 CG30090 -3.05
23 FBgn0039470 CG6296 -3.00
24 FBgn0085415 CG34386 -2.98
25 FBgn0263020 CG43315 -2.93
26 FBgn0039778 Jon99Fi -2.89
27 FBgn0033469 CG12133 -2.88
28 FBgn0039472 CG17192 -2.87
29 FBgn0043575 PGRP-SC2 -2.85
30 FBgn0263250 CG43393 -2.81
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Table 16: Dm0 overexpression vs UPD overexpression: 30 candidates with strongest increase
in transcript levels compared to control
Nr Flybase gene id external gene name log2 fold change
1 FBgn0027578 CG14526 5.06
2 FBgn0004872 piwi 4.57
3 FBgn0042110 CG18765 4.29
4 FBgn0050104 NT5E-2 4.20
5 FBgn0052279 dro2 4.19
6 FBgn0004956 os 4.03
7 FBgn0032684 CG10178 4.02
8 FBgn0035926 CG5804 4.01
9 FBgn0053543 CG33543 3.92
10 FBgn0052302 CG32302 3.82
11 FBgn0036948 CG7298 3.79
12 FBgn0031935 CG13793 3.72
13 FBgn0031936 CG13794 3.65
14 FBgn0031693 Cyp4ac1 3.62
15 FBgn0050103 CG30103 3.51
16 FBgn0039053 CG6738 3.40
17 FBgn0034462 CG15905 3.36
18 FBgn0051057 tau 3.34
19 FBgn0014073 Tie 3.29
20 FBgn0038632 CG14301 3.26
21 FBgn0032683 kon 3.22
22 FBgn0040958 Peritrophin-15b 3.19
23 FBgn0031694 Cyp4ac2 3.12
24 FBgn0033574 Spn47C 3.06
25 FBgn0053337 CG33337 3.06
26 FBgn0015400 kek2 3.05
27 FBgn0034317 CG14499 3.04
28 FBgn0036225 CG5883 3.03
29 FBgn0032856 CG16798 3.02
30 FBgn0032336 Ast-C 3.02
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Table 17: Dm0 overexpression vs UPD overexpression: 30 candidates with strongest decrease
in transcript levels compared to control
Nr Flybase gene id external gene name log2 fold change
1 FBgn0035638 Tektin-C -6.66
2 FBgn0034415 CG15116 -6.51
3 FBgn0034692 CG13502 -6.26
4 FBgn0263250 CG43393 -6.14
5 FBgn0261804 CG42750 -5.93
6 FBgn0085386 CG34357 -5.57
7 FBgn0000337 cn -5.12
8 FBgn0034506 CG13870 -4.99
9 FBgn0039551 Or98a -4.92
10 FBgn0015038 Cyp9b1 -4.91
11 FBgn0263332 -4.80
12 FBgn0033469 CG12133 -4.78
13 FBgn0263219 Dscam4 -4.76
14 FBgn0259683 Ir40a -4.64
15 FBgn0027109 npf -4.53
16 FBgn0034505 CG16739 -4.50
17 FBgn0052207 CG32207 -4.39
18 FBgn0035476 CG12766 -4.33
19 FBgn0086408 stl -4.30
20 FBgn0051774 fred -4.17
21 FBgn0053494 CG33494 -4.03
22 FBgn0035776 CG8564 -4.03
23 FBgn0264721 -4.01
24 FBgn0034910 CG4763 -3.98
25 FBgn0051728 CG31728 -3.87
26 FBgn0037975 CG3397 -3.86
27 FBgn0040091 Ugt58Fa -3.80
28 FBgn0033774 CG12374 -3.80
29 FBgn0263477 scaRNA:U1-6 -3.79
30 FBgn0051708 CG31708 -3.73
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Table 18: DAVID 6.8 GO-annotation, Control vs Dm0, upregulated transcripts, biological
process
Term Count -log10(FDR)
DNA recombination 7 3,37
telomere maintenance 7 2,78
regulation of protein stability 6 2,13
mRNA splicing, via spliceosome 21 2,06
hippo signaling 5 2,04
chromatin-mediated maintenance of transcription 4 1,37
nucleotide-excision repair 6 1,29
regulation of alternative mRNA splicing, via spliceosome 9 1,21
telomere capping 4 1,07
double-strand break repair 5 1,01




apical cortex 8 1,79
nucleolus 17 1,76
sarcomere 4 1,69
adherens junction 8 1,31
Table 20: DAVID 6.8 GO-annotation, Control vs Dm0, upregulated transcripts, molecular
function
Term Count -log10(FDR)
zinc ion binding 47 2,59
helicase activity 8 2,01
ATP binding 42 1,56
DNA binding 38 1,28
nucleic acid binding 28 1,26
RNA helicase activity 5 1,12
ATP-dependent DNA helicase activity 5 1,12
128




glutathione metabolic process 15 6,04
neuropeptide signaling pathway 17 5,87
metabolic process 25 3,35
transmembrane transport 35 2,75
chitin metabolic process 17 2,32
synaptic vesicle exocytosis 8 2,21
heat shock-mediated polytene chromosome puffing 5 2,21
G-protein coupled receptor signaling pathway 20 2,01
oxidation-reduction process 40 1,76
response to hypoxia 8 1,58
neurotransmitter secretion 15 1,39
leg disc proximal/distal pattern formation 6 1,39
cellular acyl-CoA homeostasis 4 1,02
Table 22: DAVID 6.8 GO-annotation, Control vs Dm0, downregulated transcripts, cellular
compartment
Term1 Count -log10(FDR)
integral component of membrane 103 6,60
membrane 46 3,82
integral component of plasma membrane 30 3,62
intracellular membrane-bounded organelle 16 2,78
extracellular region 51 2,59
extracellular space 41 2,21
intracellular 13 2,01
synaptic vesicle 12 1,78
presynaptic active zone 6 1,75
voltage-gated calcium channel complex 4 1,70
plasma membrane 47 1,41
basolateral plasma membrane 7 1,09
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Table 23: DAVID 6.8 GO-annotation, Control vs Dm0, downregulated transcripts, molecular
function
Term Count -log10(FDR)
serine-type endopeptidase activity 52 8,88
transfer of acyl groups 13 6,34
glutathione transferase activity 14 4,64
neuropeptide receptor activity 13 3,49
voltage-gated calcium channel activity 5 2,41
neuropeptide hormone activity 10 2,15
metallopeptidase activity 10 1,97
oxidoreductase activity 8 1,84
chitin binding 18 1,70
serine-type peptidase activity 9 1,66
heme binding 19 1,53
diazepam binding 4 1,14
hormone activity 8 1,11
lysozyme activity 6 1,11
Table 24: DAVID 6.8 GO-annotation, Control vs UPD, upregulated transcripts, biological
process
Term Count -log10(FDR)
cellular amino acid metabolic process 5 2,65
dopamine uptake involved in synaptic transmission 3 1,43
defense response 7 1,43
neurotransmitter transport 4 1,21
peptide catabolic process 4 1,03
immune response 5 1,01
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Table 25: DAVID 6.8 GO-annotation, Control vs UPD, upregulated transcripts, cellular
compartment
Term Count -log10(FDR)
extracellular region 24 4,36
integral component of plasma membrane 18 2,42
proteinaceous extracellular matrix 7 2,30
integral component of membrane 53 1,36
Table 26: DAVID 6.8 GO-annotation, Control vs UPD, upregulated transcripts, molecular
function
Term Count -log10(FDR)
metallodipeptidase activity 4 2,88
aminoacylase activity 4 2,88
dopamine:sodium symporter activity 3 1,42
neurotransmitter:sodium symporter activity 4 1,32
choline dehydrogenase activity 3 1,28




glutathione metabolic process 10 5,49
metabolic process 14 3,09
oxidation-reduction process 20 1,81
potassium ion transport 5 1,34
transmembrane transport 15 1,16
digestion 3 1,02





intracellular membrane-bounded organelle 8 1,62
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Table 29: DAVID 6.8 GO-annotation, Control vs UPD, downregulated transcripts, molecular
function
Term Count -log10(FDR)
serine-type endopeptidase activity 30 8,75
glutathione transferase activity 10 5,08
glucuronosyltransferase activity 7 3,32
metallocarboxypeptidase activity 6 2,53
glutathione peroxidase activity 4 1,81
Table 30: DAVID 6.8 GO-annotation, Control vs Dm0+UPD, upregulated transcripts, bio-
logical process
Term Count -log10(FDR)
telomere maintenance 7 2,72
DNA recombination 7 2,07
ecdysteroid metabolic process 5 2,00
dopamine uptake involved in synaptic transmission 4 1,75
double-strand break repair 6 1,75
meiotic cell cycle 5 1,69
crystal cell differentiation 4 1,52
serotonin receptor signaling pathway 4 1,34
nucleotide-excision repair 6 1,31
proteolysis 32 1,02
Table 31: DAVID 6.8 GO-annotation, Control vs Dm0+UPD, upregulated transcripts, cellular
compartment
Term Count -log10(FDR)
integral component of plasma membrane 37 1,81
extracellular region 42 1,72
proteinaceous extracellular matrix 10 1,30
nuclear chromosome, telomeric region 4 1,20
synaptonemal complex 4 1,20
Mre11 complex 3 1,20
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Table 32: DAVID 6.8 GO-annotation, Control vs Dm0+UPD, upregulated transcripts, molec-
ular function
Term Count -log10(FDR)
damaged DNA binding 9 3,63
dopamine:sodium symporter activity 4 1,74
metalloendopeptidase activity 11 1,55
choline dehydrogenase activity 4 1,52
G-protein coupled serotonin receptor activity 4 1,33




neuropeptide signaling pathway 17 6,73
oxidation-reduction process 45 5,05
G-protein coupled receptor signaling pathway 22 3,94
transmembrane transport 33 3,71
metabolic process 22 3,58
flavonoid glucuronidation 10 3,41
flavonoid biosynthetic process 10 3,41
regulation of calcium ion-dependent exocytosis 5 2,58
glutathione metabolic process 10 2,32
ion transmembrane transport 5 2,29
neurotransmitter secretion 15 2,26
calcium ion transmembrane transport 6 1,94
insecticide catabolic process 7 1,71
response to DDT 7 1,53
cytoskeletal matrix organization at active zone 4 1,28
calcium ion-regulated exocytosis of neurotransmitter 4 1,28
synaptic vesicle exocytosis 6 1,11
cellular water homeostasis 4 1,10
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Table 34: DAVID 6.8 GO-annotation, Control vs Dm0+UPD, downregulated transcripts,
cellular compartment
Term Count -log10(FDR)
integral component of membrane 225 14,26
integral component of plasma membrane 60 8,15
intracellular membrane-bounded organelle 28 7,62
membrane 50 5,50
voltage-gated calcium channel complex 6 4,14
synaptic vesicle 14 3,43
plasma membrane 67 2,72
extracellular space 45 1,54
basolateral plasma membrane 7 1,14
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Table 35: DAVID 6.8 GO-annotation, Control vs Dm0+UPD, downregulated transcripts,
molecular function
Term Count -log10(FDR)
serine-type endopeptidase activity 42 6,79
oxidoreductase activity, acting on paired donors, with
incorporation or reduction of molecular oxygen
19 4,60
neuropeptide hormone activity 11 3,88
electron carrier activity 22 3,66
neuropeptide receptor activity 12 3,58
monooxygenase activity 17 3,54
heme binding 21 3,33
iron ion binding 22 3,18
UDP-glycosyltransferase activity 10 2,82
glutathione peroxidase activity 9 2,64
voltage-gated calcium channel activity 5 2,40
calcium ion binding 26 2,33
glutathione transferase activity 10 2,19
oxidoreductase activity, acting on CH-OH group of donors 8 1,85
lysozyme activity 6 1,48
glycerol channel activity 4 1,17
water channel activity 4 1,17
oxidoreductase activity 19 1,08
metallocarboxypeptidase activity 6 1,00
Table 36: Control vs Dm0 overexpression: 5 hippo pathway candidates with increase in
transcript levels compared to control
Nr Flybase gene id external gene name log2 fold change
1 FBgn0030530 Ajuba(jub) 1,04
2 FBgn0000212 brahma(brm) 1,09
3 FBgn0053193 salvador(sav) 1,03
4 FBgn0086384 Merlin(Mer) 1,13
5 FBgn0001075 fat(ft) 1,81
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